data_16587 ####################### # Entry information # ####################### save_entry_information _Entry.Sf_category entry_information _Entry.Sf_framecode entry_information _Entry.ID 16587 _Entry.Title ; Chemical shifts of a native-like folding intermediate of beta2-microglobulin ; _Entry.Type macromolecule _Entry.Version_type original _Entry.Submission_date 2009-10-27 _Entry.Accession_date 2009-10-27 _Entry.Last_release_date . _Entry.Original_release_date . _Entry.Origination author _Entry.NMR_STAR_version 3.1.1.61 _Entry.Original_NMR_STAR_version 3.0.9.13 _Entry.Experimental_method NMR _Entry.Experimental_method_subtype solution _Entry.Details 'Partial 1H and 15N assignment of a native-like folding intermediate of beta2-microglobulin in 18% TFE at 306 K' _Entry.BMRB_internal_directory_name . loop_ _Entry_author.Ordinal _Entry_author.Given_name _Entry_author.Family_name _Entry_author.First_initial _Entry_author.Middle_initials _Entry_author.Family_title _Entry_author.Entry_ID 1 Enrico Rennella . . . 16587 2 Gennaro Esposito . . . 16587 3 Alessandra Corazza . . . 16587 4 Sofia Giorgetti . . . 16587 5 Monica Stoppini . . . 16587 6 Vittorio Bellotti . . . 16587 stop_ loop_ _Entry_src.ID _Entry_src.Project_name _Entry_src.Organization_full_name _Entry_src.Organization_initials _Entry_src.Entry_ID 1 . 'Dipartimento di Scienze e Tecnologie Biomediche, Universita` di Udine' . 16587 stop_ loop_ _Data_set.Type _Data_set.Count _Data_set.Entry_ID assigned_chemical_shifts 1 16587 stop_ loop_ _Datum.Type _Datum.Count _Datum.Entry_ID '15N chemical shifts' 65 16587 '1H chemical shifts' 398 16587 stop_ loop_ _Release.Release_number _Release.Format_type _Release.Format_version _Release.Date _Release.Submission_date _Release.Type _Release.Author _Release.Detail _Release.Entry_ID 2 . . 2010-05-18 2009-10-27 update BMRB 'complete entry citation' 16587 1 . . 2010-02-09 2009-10-27 original author 'original release' 16587 stop_ loop_ _Related_entries.Database_name _Related_entries.Database_accession_code _Related_entries.Relationship _Related_entries.Entry_ID BMRB 15480 w60g-b2m 16587 PDB 1JNJ . 16587 PDB 2VB5 . 16587 stop_ save_ ############### # Citations # ############### save_citation_1 _Citation.Sf_category citations _Citation.Sf_framecode citation_1 _Citation.Entry_ID 16587 _Citation.ID 1 _Citation.Class 'entry citation' _Citation.CAS_abstract_code . _Citation.MEDLINE_UI_code . _Citation.DOI . _Citation.PubMed_ID 20028983 _Citation.Full_citation . _Citation.Title 'Native-unlike long-lived intermediates along the folding pathway of the amyloidogenic protein beta2-microglobulin revealed by real-time two-dimensional NMR.' _Citation.Status published _Citation.Type journal _Citation.Journal_abbrev 'J. Biol. Chem.' _Citation.Journal_name_full 'The Journal of biological chemistry' _Citation.Journal_volume 285 _Citation.Journal_issue 8 _Citation.Journal_ASTM . _Citation.Journal_ISSN . _Citation.Journal_CSD . _Citation.Book_title . _Citation.Book_chapter_title . _Citation.Book_volume . _Citation.Book_series . _Citation.Book_publisher . _Citation.Book_publisher_city . _Citation.Book_ISBN . _Citation.Conference_title . _Citation.Conference_site . _Citation.Conference_state_province . _Citation.Conference_country . _Citation.Conference_start_date . _Citation.Conference_end_date . _Citation.Conference_abstract_number . _Citation.Thesis_institution . _Citation.Thesis_institution_city . _Citation.Thesis_institution_country . _Citation.WWW_URL . _Citation.Page_first 5827 _Citation.Page_last 5835 _Citation.Year 2010 _Citation.Details . loop_ _Citation_author.Ordinal _Citation_author.Given_name _Citation_author.Family_name _Citation_author.First_initial _Citation_author.Middle_initials _Citation_author.Family_title _Citation_author.Entry_ID _Citation_author.Citation_ID 1 Alessandra Corazza . . . 16587 1 2 Enrico Rennella . . . 16587 1 3 Paul Schanda . . . 16587 1 4 'Maria Chiara' Mimmi . . . 16587 1 5 Thomas Cutuil . . . 16587 1 6 Sara Raimondi . . . 16587 1 7 Sofia Giorgetti . . . 16587 1 8 Federico Fogolari . . . 16587 1 9 Paolo Viglino . . . 16587 1 10 Lucio Frydman . . . 16587 1 11 Maayan Gal . . . 16587 1 12 Vittorio Bellotti . . . 16587 1 13 Bernhard Brutscher . . . 16587 1 14 Gennaro Esposito . . . 16587 1 stop_ save_ save_citation_2 _Citation.Sf_category citations _Citation.Sf_framecode citation_2 _Citation.Entry_ID 16587 _Citation.ID 2 _Citation.Class 'reference citation' _Citation.CAS_abstract_code . _Citation.MEDLINE_UI_code . _Citation.DOI . _Citation.PubMed_ID . _Citation.Full_citation . _Citation.Title 'Folding and fibrillogenesis: clues from beta2-microglobulin in aqueous trifluoroethanol' _Citation.Status submitted _Citation.Type journal _Citation.Journal_abbrev na _Citation.Journal_name_full . _Citation.Journal_volume . _Citation.Journal_issue . _Citation.Journal_ASTM . _Citation.Journal_ISSN . _Citation.Journal_CSD . _Citation.Book_title . _Citation.Book_chapter_title . _Citation.Book_volume . _Citation.Book_series . _Citation.Book_publisher . _Citation.Book_publisher_city . _Citation.Book_ISBN . _Citation.Conference_title . _Citation.Conference_site . _Citation.Conference_state_province . _Citation.Conference_country . _Citation.Conference_start_date . _Citation.Conference_end_date . _Citation.Conference_abstract_number . _Citation.Thesis_institution . _Citation.Thesis_institution_city . _Citation.Thesis_institution_country . _Citation.WWW_URL . _Citation.Page_first . _Citation.Page_last . _Citation.Year . _Citation.Details . loop_ _Citation_author.Ordinal _Citation_author.Given_name _Citation_author.Family_name _Citation_author.First_initial _Citation_author.Middle_initials _Citation_author.Family_title _Citation_author.Entry_ID _Citation_author.Citation_ID 1 Enrico Rennella . . . 16587 2 2 Alessandra Corazza . . . 16587 2 3 Sofia Giorgetti . . . 16587 2 4 Federico Fogolari . . . 16587 2 5 Paolo Viglino . . . 16587 2 6 Riccardo Porcari . . . 16587 2 7 Monica Stoppini . . . 16587 2 8 Vittorio Bellotti . . . 16587 2 9 Gennaro Esposito . . . 16587 2 stop_ save_ save_citation_3 _Citation.Sf_category citations _Citation.Sf_framecode citation_3 _Citation.Entry_ID 16587 _Citation.ID 3 _Citation.Class 'reference citation' _Citation.CAS_abstract_code . _Citation.MEDLINE_UI_code . _Citation.DOI . _Citation.PubMed_ID 19606503 _Citation.Full_citation . _Citation.Title 'NMR-based characterization of a refolding intermediate of beta2-microglobulin labeled using a wheat germ cell-free system.' _Citation.Status published _Citation.Type journal _Citation.Journal_abbrev 'Protein Sci.' _Citation.Journal_name_full . _Citation.Journal_volume . _Citation.Journal_issue . _Citation.Journal_ASTM . _Citation.Journal_ISSN . _Citation.Journal_CSD . _Citation.Book_title . _Citation.Book_chapter_title . _Citation.Book_volume . _Citation.Book_series . _Citation.Book_publisher . _Citation.Book_publisher_city . _Citation.Book_ISBN . _Citation.Conference_title . _Citation.Conference_site . _Citation.Conference_state_province . _Citation.Conference_country . _Citation.Conference_start_date . _Citation.Conference_end_date . _Citation.Conference_abstract_number . _Citation.Thesis_institution . _Citation.Thesis_institution_city . _Citation.Thesis_institution_country . _Citation.WWW_URL . _Citation.Page_first . _Citation.Page_last . _Citation.Year . _Citation.Details . loop_ _Citation_author.Ordinal _Citation_author.Given_name _Citation_author.Family_name _Citation_author.First_initial _Citation_author.Middle_initials _Citation_author.Family_title _Citation_author.Entry_ID _Citation_author.Citation_ID 1 A. Kameda . . . 16587 3 2 E. Morita . H. . 16587 3 3 K. Sakurai . . . 16587 3 4 H. Naiki . . . 16587 3 5 Y. Goto . . . 16587 3 stop_ save_ save_citation_4 _Citation.Sf_category citations _Citation.Sf_framecode citation_4 _Citation.Entry_ID 16587 _Citation.ID 4 _Citation.Class 'reference citation' _Citation.CAS_abstract_code . _Citation.MEDLINE_UI_code . _Citation.DOI . _Citation.PubMed_ID 15811375 _Citation.Full_citation . _Citation.Title 'Nuclear magnetic resonance characterization of the refolding intermediate of beta2-microglobulin trapped by non-native prolyl peptide bond.' _Citation.Status published _Citation.Type journal _Citation.Journal_abbrev 'J. Mol. Biol.' _Citation.Journal_name_full . _Citation.Journal_volume . _Citation.Journal_issue . _Citation.Journal_ASTM . _Citation.Journal_ISSN . _Citation.Journal_CSD . _Citation.Book_title . _Citation.Book_chapter_title . _Citation.Book_volume . _Citation.Book_series . _Citation.Book_publisher . _Citation.Book_publisher_city . _Citation.Book_ISBN . _Citation.Conference_title . _Citation.Conference_site . _Citation.Conference_state_province . _Citation.Conference_country . _Citation.Conference_start_date . _Citation.Conference_end_date . _Citation.Conference_abstract_number . _Citation.Thesis_institution . _Citation.Thesis_institution_city . _Citation.Thesis_institution_country . _Citation.WWW_URL . _Citation.Page_first . _Citation.Page_last . _Citation.Year . _Citation.Details . loop_ _Citation_author.Ordinal _Citation_author.Given_name _Citation_author.Family_name _Citation_author.First_initial _Citation_author.Middle_initials _Citation_author.Family_title _Citation_author.Entry_ID _Citation_author.Citation_ID 1 A. Kameda . . . 16587 4 2 M. Hoshino . . . 16587 4 3 T. Higurashi . . . 16587 4 4 S. Takahashi . . . 16587 4 5 H. Naiki . . . 16587 4 6 Y. Goto . . . 16587 4 stop_ save_ ############################################# # Molecular system (assembly) description # ############################################# save_assembly _Assembly.Sf_category assembly _Assembly.Sf_framecode assembly _Assembly.Entry_ID 16587 _Assembly.ID 1 _Assembly.Name 'W60G beta2-microglobulin' _Assembly.BMRB_code . _Assembly.Number_of_components . _Assembly.Organic_ligands . _Assembly.Metal_ions . _Assembly.Non_standard_bonds no _Assembly.Ambiguous_conformational_states . _Assembly.Ambiguous_chem_comp_sites . _Assembly.Molecules_in_chemical_exchange . _Assembly.Paramagnetic no _Assembly.Thiol_state . _Assembly.Molecular_mass . _Assembly.Enzyme_commission_number . _Assembly.Details . _Assembly.DB_query_date . _Assembly.DB_query_revised_last_date . loop_ _Entity_assembly.ID _Entity_assembly.Entity_assembly_name _Entity_assembly.Entity_ID _Entity_assembly.Entity_label _Entity_assembly.Asym_ID _Entity_assembly.PDB_chain_ID _Entity_assembly.Experimental_data_reported _Entity_assembly.Physical_state _Entity_assembly.Conformational_isomer _Entity_assembly.Chemical_exchange_state _Entity_assembly.Magnetic_equivalence_group_code _Entity_assembly.Role _Entity_assembly.Details _Entity_assembly.Entry_ID _Entity_assembly.Assembly_ID 1 'W60G beta2-microglobulin' 1 $entity A . yes native yes yes . . . 16587 1 stop_ loop_ _Bond.ID _Bond.Type _Bond.Value_order _Bond.Assembly_atom_ID_1 _Bond.Entity_assembly_ID_1 _Bond.Entity_assembly_name_1 _Bond.Entity_ID_1 _Bond.Comp_ID_1 _Bond.Comp_index_ID_1 _Bond.Seq_ID_1 _Bond.Atom_ID_1 _Bond.Assembly_atom_ID_2 _Bond.Entity_assembly_ID_2 _Bond.Entity_assembly_name_2 _Bond.Entity_ID_2 _Bond.Comp_ID_2 _Bond.Comp_index_ID_2 _Bond.Seq_ID_2 _Bond.Atom_ID_2 _Bond.Auth_entity_assembly_ID_1 _Bond.Auth_entity_assembly_name_1 _Bond.Auth_seq_ID_1 _Bond.Auth_comp_ID_1 _Bond.Auth_atom_ID_1 _Bond.Auth_entity_assembly_ID_2 _Bond.Auth_entity_assembly_name_2 _Bond.Auth_seq_ID_2 _Bond.Auth_comp_ID_2 _Bond.Auth_atom_ID_2 _Bond.Entry_ID _Bond.Assembly_ID 1 disulfide single . 1 . 1 CYS 26 26 SG . 1 . 1 CYS 81 81 SG . . . . . . . . . . 16587 1 stop_ save_ #################################### # Biological polymers and ligands # #################################### save_entity _Entity.Sf_category entity _Entity.Sf_framecode entity _Entity.Entry_ID 16587 _Entity.ID 1 _Entity.BMRB_code . _Entity.Name 'W60G beta2-microglobulin' _Entity.Type polymer _Entity.Polymer_common_type . _Entity.Polymer_type polypeptide(L) _Entity.Polymer_type_details . _Entity.Polymer_strand_ID . _Entity.Polymer_seq_one_letter_code_can . _Entity.Polymer_seq_one_letter_code ; MIQRTPKIQVYSRHPAENGK SNFLNCYVSGFHPSDIEVDL LKNGERIEKVEHSDLSFSKD GSFYLLYYTEFTPTEKDEYA CRVNHVTLSQPKIVKWDRDM ; _Entity.Target_identifier . _Entity.Polymer_author_defined_seq . _Entity.Polymer_author_seq_details . _Entity.Ambiguous_conformational_states no _Entity.Ambiguous_chem_comp_sites no _Entity.Nstd_monomer no _Entity.Nstd_chirality no _Entity.Nstd_linkage no _Entity.Nonpolymer_comp_ID . _Entity.Nonpolymer_comp_label . _Entity.Number_of_monomers 100 _Entity.Number_of_nonpolymer_components . _Entity.Paramagnetic no _Entity.Thiol_state 'all disulfide bound' _Entity.Src_method . _Entity.Parent_entity_ID . _Entity.Fragment . _Entity.Mutation W60G _Entity.EC_number . _Entity.Calc_isoelectric_point . _Entity.Formula_weight . _Entity.Formula_weight_exptl . _Entity.Formula_weight_exptl_meth . _Entity.Details . _Entity.DB_query_date . _Entity.DB_query_revised_last_date 2015-11-25 loop_ _Entity_db_link.Ordinal _Entity_db_link.Author_supplied _Entity_db_link.Database_code _Entity_db_link.Accession_code _Entity_db_link.Entry_mol_code _Entity_db_link.Entry_mol_name _Entity_db_link.Entry_experimental_method _Entity_db_link.Entry_structure_resolution _Entity_db_link.Entry_relation_type _Entity_db_link.Entry_details _Entity_db_link.Chimera_segment_ID _Entity_db_link.Seq_query_to_submitted_percent _Entity_db_link.Seq_subject_length _Entity_db_link.Seq_identity _Entity_db_link.Seq_positive _Entity_db_link.Seq_homology_expectation_val _Entity_db_link.Seq_align_begin _Entity_db_link.Seq_align_end _Entity_db_link.Seq_difference_details _Entity_db_link.Seq_alignment_details _Entity_db_link.Entry_ID _Entity_db_link.Entity_ID 1 no BMRB 15480 . w60g-b2m . . . . . 100.00 100 100.00 100.00 3.13e-68 . . . . 16587 1 2 no BMRB 17165 . WT . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 3 no BMRB 17166 . dN6 . . . . . 93.00 94 98.92 98.92 3.63e-61 . . . . 16587 1 4 no BMRB 19099 . human_beta-2_microglobulin . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 5 no BMRB 19113 . human_beta-2_microglobulin . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 6 no BMRB 19116 . human_beta-2_microglobulin . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 7 no BMRB 19118 . human_beta-2_microglobulin . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 8 no BMRB 19119 . human_beta-2_microglobulin . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 9 no BMRB 19120 . human_beta-2_microglobulin . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 10 no BMRB 19121 . human_beta-2_microglobulin . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 11 no BMRB 19122 . human_beta-2_microglobulin . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 12 no BMRB 19123 . human_beta-2_microglobulin . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 13 no BMRB 3078 . microglobulin . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 14 no BMRB 3079 . microglobulin . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 15 no PDB 1A1M . "Mhc Class I Molecule B5301 Complexed With Peptide Tpydinqml From Gag Protein Of Hiv2" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 16 no PDB 1A1N . "Mhc Class I Molecule B3501 Complexed With Peptide Vplrpmty From The Nef Protein (75-82) Of Hiv1" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 17 no PDB 1A1O . "Mhc Class I Molecule B5301 Complexed With Peptide Ls6 (Kpivqydnf) From The Malaria Parasite P. Falciparum" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 18 no PDB 1A6Z . "Hfe (Human) Hemochromatosis Protein" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 19 no PDB 1A9B . "Decamer-Like Conformation Of A Nano-Peptide Bound To Hla- B3501 Due To Nonstandard Positioning Of The C-Terminus" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 20 no PDB 1A9E . "Decamer-Like Conformation Of A Nano-Peptide Bound To Hla- B3501 Due To Nonstandard Positioning Of The C-Terminus" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 21 no PDB 1AGB . "Antagonist Hiv-1 Gag Peptides Induce Structural Changes In Hla B8-Hiv-1 Gag Peptide (Ggrkkykl-3r Mutation)" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 22 no PDB 1AGC . "Antagonist Hiv-1 Gag Peptides Induce Structural Changes In Hla B8-Hiv-1 Gag Peptide (Ggkkkyql-7q Mutation)" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 23 no PDB 1AGD . "Antagonist Hiv-1 Gag Peptides Induce Structural Changes In Hla B8-Hiv-1 Gag Peptide (Ggkkkykl-Index Peptide)" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 24 no PDB 1AGE . "Antagonist Hiv-1 Gag Peptides Induce Structural Changes In Hla B8-Hiv-1 Gag Peptide (Ggkkkyrl-7r Mutation)" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 25 no PDB 1AGF . "Antagonist Hiv-1 Gag Peptides Induce Structural Changes In Hla B8-Hiv-1 Gag Peptide (Ggkkrykl-5r Mutation)" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 26 no PDB 1AKJ . "Complex Of The Human Mhc Class I Glycoprotein Hla-A2 And The T Cell Coreceptor Cd8" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 27 no PDB 1AO7 . "Complex Between Human T-Cell Receptor, Viral Peptide (Tax), And Hla-A 0201" . . . . . 100.00 100 97.00 97.00 2.06e-64 . . . . 16587 1 28 no PDB 1B0G . "Class I Histocompatibility Antigen (hla-a2.1)/beta 2- Microglobulin/peptide P1049 Complex" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 29 no PDB 1B0R . "Crystal Structure Of Hla-A0201 Complexed With A Peptide With The Carboxyl-Terminal Group Substituted By A Methyl Group" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 30 no PDB 1BD2 . "Complex Between Human T-Cell Receptor B7, Viral Peptide (Tax) And Mhc Class I Molecule Hla-A 0201" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 31 no PDB 1C16 . "Crystal Structure Analysis Of The GammaDELTA T CELL LIGAND T22" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 32 no PDB 1CE6 . "Mhc Class I H-2db Complexed With A Sendai Virus Nucleoprotein Peptide" . . . . . 99.00 108 98.99 98.99 1.33e-65 . . . . 16587 1 33 no PDB 1CG9 . "Complex Recognition Of The Supertypic Bw6-Determinant On Hla-B And-C Molecules By The Monoclonal Antibody Sfr8-B6" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 34 no PDB 1DE4 . "Hemochromatosis Protein Hfe Complexed With Transferrin Receptor" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 35 no PDB 1DUY . "Crystal Structure Of Hla-A0201OCTAMERIC TAX PEPTIDE Complex" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 36 no PDB 1DUZ . "Human Class I Histocompatibility Antigen (Hla-A 0201) In Complex With A Nonameric Peptide From Htlv-1 Tax Protein" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 37 no PDB 1E27 . "Nonstandard Peptide Binding Of Hla-B5101 Complexed With Hiv Immunodominant Epitope Km1(Lppvvakei)" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 38 no PDB 1E28 . "Nonstandard Peptide Binding Of Hla-B5101 Complexed With Hiv Immunodominant Epitope Km2(Taftipsi)" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 39 no PDB 1EEY . "Crystal Structure Determination Of Hla A2 Complexed To Peptide Gp2 With The Substitution (I2lV5LL9V)" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 40 no PDB 1EEZ . "Crystal Structure Determination Of Hla-A2.1 Complexed To Gp2 Peptide Variant(I2lV5L)" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 41 no PDB 1EFX . "Structure Of A Complex Between The Human Natural Killer Cell Receptor Kir2dl2 And A Class I Mhc Ligand Hla-Cw3" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 42 no PDB 1EXU . "Crystal Structure Of The Human Mhc-Related Fc Receptor" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 43 no PDB 1GZP . "Cd1b In Complex With Gm2 Ganglioside" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 44 no PDB 1GZQ . "Cd1b In Complex With Phophatidylinositol" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 45 no PDB 1HHG . "The Antigenic Identity Of Peptide(Slash)mhc Complexes: A Comparison Of The Conformation Of Five Peptides Presented By Hla-A2" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 46 no PDB 1HHH . "The Antigenic Identity Of Peptide(Slash)mhc Complexes: A Comparison Of The Conformation Of Five Peptides Presented By Hla-A2" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 47 no PDB 1HHI . "The Antigenic Identity Of Peptide(Slash)mhc Complexes: A Comparison Of The Conformation Of Five Peptides Presented By Hla-A2" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 48 no PDB 1HHJ . "The Antigenic Identity Of Peptide(Slash)mhc Complexes: A Comparison Of The Conformation Of Five Peptides Presented By Hla-A2" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 49 no PDB 1HHK . "The Antigenic Identity Of Peptide(Slash)mhc Complexes: A Comparison Of The Conformation Of Five Peptides Presented By Hla-A2" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 50 no PDB 1HLA . "Structure Of The Human Class I Histocompatibility Antigen, Hla-A2" . . . . . 97.00 97 98.97 98.97 3.82e-64 . . . . 16587 1 51 no PDB 1HSA . "The Three-Dimensional Structure Of Hla-B27 At 2.1 Angstroms Resolution Suggests A General Mechanism For Tight Peptide Binding T" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 52 no PDB 1HSB . "Different Length Peptides Bind To Hla-Aw68 Similarly At Their Ends But Bulge Out In The Middle" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 53 no PDB 1I1F . "Crystal Structure Of Human Class I Mhc (Hla-A2.1) Complexed With Beta 2-Microglobulin And Hiv-Rt Variant Peptide I1y" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 54 no PDB 1I1Y . "Crystal Structure Of Human Class I Mhc (Hla-A2.1) Complexed With Beta 2-Microglobulin And Hiv-Rt Variant Peptide I1y" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 55 no PDB 1I4F . "Crystal Structure Of Hla-A0201MAGE-A4-Peptide Complex" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 56 no PDB 1I7R . "Crystal Structure Of Class I Mhc A2 In Complex With Peptide P1058" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 57 no PDB 1I7T . "Crystal Structure Of Class I Mhc A2 In Complex With Peptide P1049-5v" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 58 no PDB 1I7U . "Crystal Structure Of Class I Mhc A2 In Complex With Peptide P1049-6v" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 59 no PDB 1IM3 . "Crystal Structure Of The Human Cytomegalovirus Protein Us2 Bound To The Mhc Class I Molecule Hla-A2TAX" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 60 no PDB 1IM9 . "Crystal Structure Of The Human Natural Killer Cell Inhibitory Receptor Kir2dl1 Bound To Its Mhc Ligand Hla-Cw4" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 61 no PDB 1JF1 . "Crystal Structure Of Hla-A20201 In Complex With A Decameric Altered Peptide Ligand From The Mart-1MELAN-A" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 62 no PDB 1JGD . "Hla-B2709 Bound To Deca-Peptide S10r" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 63 no PDB 1JGE . "Hla-B2705 Bound To Nona-Peptide M9" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 64 no PDB 1JHT . "Crystal Structure Of Hla-A20201 In Complex With A Nonameric Altered Peptide Ligand (Algigiltv) From The Mart- 1MELAN-A." . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 65 no PDB 1JNJ . "Nmr Solution Structure Of The Human Beta2-Microglobulin" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 66 no PDB 1K5N . "Hla-B2709 Bound To Nona-Peptide M9" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 67 no PDB 1KPR . "The Human Non-Classical Major Histocompatibility Complex Molecule Hla-E" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 68 no PDB 1KTL . "The Human Non-Classical Major Histocompatibility Complex Molecule Hla-E" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 69 no PDB 1LDS . "Crystal Structure Of Monomeric Human Beta-2-Microglobulin" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 70 no PDB 1LP9 . "Xenoreactive Complex Ahiii 12.2 Tcr Bound To P1049HLA-A2.1" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 71 no PDB 1M05 . "Hla B8 In Complex With An Epstein Barr Virus Determinant" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 72 no PDB 1M6O . "Crystal Structure Of Hla B4402 In Complex With Hla Dpa0201 Peptide" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 73 no PDB 1MHE . "The Human Non-Classical Major Histocompatibility Complex Molecule Hla-E" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 74 no PDB 1MI5 . "The Crystal Structure Of Lc13 Tcr In Complex With Hlab8-Ebv Peptide Complex" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 75 no PDB 1N2R . "A Natural Selected Dimorphism In Hla B44 Alters Self, Peptide Reportoire And T Cell Recognition." . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 76 no PDB 1OF2 . "Crystal Structure Of Hla-B2709 Complexed With The Vasoactive Intestinal Peptide Type 1 Receptor (Vipr) Peptide (Residues 400-40" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 77 no PDB 1OGA . "A Structural Basis For Immunodominant Human T-Cell Receptor Recognition." . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 78 no PDB 1OGT . "Crystal Structure Of Hla-B2705 Complexed With The Vasoactive Intestinal Peptide Type 1 Receptor (Vipr) Peptide (Residues 400-40" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 79 no PDB 1ONQ . "Crystal Structure Of Cd1a In Complex With A Sulfatide" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 80 no PDB 1P7Q . "Crystal Structure Of Hla-A2 Bound To Lir-1, A Host And Viral Mhc Receptor" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 81 no PDB 1PY4 . "Beta2 Microglobulin Mutant H31y Displays Hints For Amyloid Formations" . . . . . 100.00 100 98.00 99.00 4.94e-66 . . . . 16587 1 82 no PDB 1Q94 . "Structures Of Hla-A1101 In Complex With Immunodominant Nonamer And Decamer Hiv-1 Epitopes Clearly Reveal The Presence Of A Midd" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 83 no PDB 1QEW . "Human Class I Histocompatibility Antigen (Hla-A 0201) Complex With A Nonameric Peptide From Melanoma-Associated Antigen 3 (Resi" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 84 no PDB 1QLF . "Mhc Class I H-2db Complexed With Glycopeptide K3g" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 85 no PDB 1QQD . "Crystal Structure Of Hla-Cw4, A Ligand For The Kir2d Natural Killer Cell Inhibitory Receptor" . . . . . 99.00 99 97.98 97.98 5.06e-65 . . . . 16587 1 86 no PDB 1QR1 . "Poor Binding Of A Her-2NEU EPITOPE (GP2) TO HLA-A2.1 Is Due To A Lack Of Interactions In The Center Of The Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 87 no PDB 1QRN . "Crystal Structure Of Human A6 Tcr Complexed With Hla-A2 Bound To Altered Htlv-1 Tax Peptide P6a" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 88 no PDB 1QSE . "Structure Of Human A6-Tcr Bound To Hla-A2 Complexed With Altered Htlv-1 Tax Peptide V7r" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 89 no PDB 1QSF . "Structure Of A6-Tcr Bound To Hla-A2 Complexed With Altered Htlv-1 Tax Peptide Y8a" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 90 no PDB 1QVO . "Structures Of Hla-A1101 In Complex With Immunodominant Nonamer And Decamer Hiv-1 Epitopes Clearly Reveal The Presence Of A Midd" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 91 no PDB 1R3H . "Crystal Structure Of T10" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 92 no PDB 1S8D . "Structural Basis For Degenerate Recognition Of Hiv Peptide Variants By Cytotoxic Lymphocyte, Variant Sl9-3a" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 93 no PDB 1S9W . "Crystal Structure Analysis Of Ny-eso-1 Epitope, Sllmwitqc, In Complex With Hla-a2" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 94 no PDB 1S9X . "Crystal Structure Analysis Of Ny-Eso-1 Epitope Analogue, Sllmwitqa, In Complex With Hla-A2" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 95 no PDB 1S9Y . "Crystal Structure Analysis Of Ny-Eso-1 Epitope Analogue, Sllmwitqs, In Complex With Hla-A2" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 96 no PDB 1SYS . "Crystal Structure Of Hla, B4403, And Peptide Eeptvikky" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 97 no PDB 1SYV . "Hla-B4405 Complexed To The Dominant Self Ligand Eefgraygf" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 98 no PDB 1T1W . "Structural Basis For Degenerate Recognition Of Hiv Peptide Variants By Cytotoxic Lymphocyte, Variant Sl9-3f6i8v" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 99 no PDB 1T1X . "Structural Basis For Degenerate Recognition Of Hiv Peptide Variants By Cytotoxic Lymphocyte, Variant Sl9-4l" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 100 no PDB 1T1Y . "Structural Basis For Degenerate Recognition Of Hiv Peptide Variants By Cytotoxic Lymphocyte, Variant Sl9-5v" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 101 no PDB 1T1Z . "Structural Basis For Degenerate Recognition Of Hiv Peptide Variants By Cytotoxic Lymphocyte, Variant Sl9-6a" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 102 no PDB 1T20 . "Structural Basis For Degenerate Recognition Of Hiv Peptide Variants By Cytotoxic Lymphocyte, Variant Sl9-6i" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 103 no PDB 1T21 . "Structural Basis For Degenerate Recognition Of Hiv Peptide Variants By Cytotoxic Lymphocyte, Variant Sl9, Monoclinic Crystal" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 104 no PDB 1T22 . "Structural Basis For Degenerate Recognition Of Hiv Peptide Variants By Cytotoxic Lymphocyte, Variant Sl9, Orthorhombic Crystal" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 105 no PDB 1TMC . "The Three-Dimensional Structure Of A Class I Major Histocompatibility Complex Molecule Missing The Alpha3 Domain Of The Heavy C" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 106 no PDB 1TVB . "Crystal Structure Of Melanoma Antigen Gp100(209-217) Bound To Human Class I Mhc Hla-A2" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 107 no PDB 1TVH . "Crystal Structure Of Modified Melanoma Antigen Gp100(209-T2m) Bound To Human Class I Mhc Hla-A2" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 108 no PDB 1UQS . "The Crystal Structure Of Human Cd1b With A Bound Bacterial Glycolipid" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 109 no PDB 1UXS . "Crystal Structure Of Hla-B2705 Complexed With The Latent Membrane Protein 2 Peptide (Lmp2)of Epstein-Barr Virus" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 110 no PDB 1UXW . "Crystal Structure Of Hla-B2709 Complexed With The Latent Membrane Protein 2 Peptide (Lmp2) Of Epstein-Barr Virus" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 111 no PDB 1VGK . "The Crystal Structure Of Class I Major Histocompatibility Complex, H-2kd At 2.0 A Resolution" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 112 no PDB 1W0V . "Crystal Structure Of Hla-B2705 Complexed With The Self-Peptide Tis From Egf-Response Factor 1" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 113 no PDB 1W0W . "Crystal Structure Of Hla-B2709 Complexed With The Self-Peptide Tis From Egf-Response Factor 1" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 114 no PDB 1W72 . "Crystal Structure Of Hla-A1:mage-A1 In Complex With Fab- Hyb3" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 115 no PDB 1X7Q . "Crystal Structure Of Hla-A1101 With Sars Nucleocapsid Peptide" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 116 no PDB 1XH3 . "Conformational Restraints And Flexibility Of 14-Meric Peptides In Complex With Hla-B3501" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 117 no PDB 1XR8 . "Crystal Structures Of Hla-B1501 In Complex With Peptides From Human Ubch6 And Epstein-Barr Virus Ebna-3" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 118 no PDB 1XR9 . "Crystal Structures Of Hla-B1501 In Complex With Peptides From Human Ubch6 And Epstein-Barr Virus Ebna-3" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 119 no PDB 1XZ0 . "Crystal Structure Of Cd1a In Complex With A Synthetic Mycobactin Lipopeptide" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 120 no PDB 1YDP . "1.9a Crystal Structure Of Hla-G" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 121 no PDB 1YPZ . "Immune Receptor" . . . . . 99.00 102 98.99 98.99 7.13e-66 . . . . 16587 1 122 no PDB 1ZHK . "Crystal Structure Of Hla-b*3501 Presenting 13-mer Ebv Antigen Lpeplpqgqltay" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 123 no PDB 1ZHL . "Crystal Structure Of Hla-b*3508 Presenting 13-mer Ebv Antigen Lpeplpqgqltay" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 124 no PDB 1ZS8 . "Crystal Structure Of The Murine Mhc Class Ib Molecule M10.5" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 125 no PDB 1ZSD . "Crystal Structure Of Hla-B3501 Presenting An 11-Mer Ebv Antigen Eplpqgqltay" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 126 no PDB 1ZT4 . "The Crystal Structure Of Human Cd1d With And Without Alpha- Galactosylceramide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 127 no PDB 1ZVS . "Crystal Structure Of The First Class Mhc Mamu And Tat-Tl8 Complex" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 128 no PDB 2A83 . "Crystal Structure Of Hla-B2705 Complexed With The Glucagon Receptor (Gr) Peptide (Residues 412-420)" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 129 no PDB 2AK4 . "Crystal Structure Of Sb27 Tcr In Complex With Hla-B3508- 13mer Peptide" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 130 no PDB 2AV1 . "Crystal Structure Of Htlv-1 Tax Peptide Bound To Human Class I Mhc Hla-A2 With The E63q And K66a Mutations In The Heavy Chain." . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 131 no PDB 2AV7 . "Crystal Structure Of Htlv-1 Tax Peptide Bound To Human Class I Mhc Hla-A2 With The K66a Mutation In The Heavy Chain." . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 132 no PDB 2AXF . "The Immunogenicity Of A Viral Cytotoxic T Cell Epitope Is Controlled By Its Mhc-Bound Conformation" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 133 no PDB 2AXG . "The Immunogenicity Of A Viral Cytotoxic T Cell Epitope Is Controlled By Its Mhc-Bound Conformation" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 134 no PDB 2BCK . "Crystal Structure Of Hla-A2402 Complexed With A Telomerase Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 135 no PDB 2BNQ . "Structural And Kinetic Basis For Heightened Immunogenicity Of T Cell Vaccines" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 136 no PDB 2BNR . "Structural And Kinetic Basis For Heightened Immunogenicity Of T Cell Vaccines" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 137 no PDB 2BSR . "Crystal Structures And Kir3dl1 Recognition Of Three Immunodominant Viral Peptides Complexed To Hla-B2705" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 138 no PDB 2BSS . "Crystal Structures And Kir3dl1 Recognition Of Three Immunodominant Viral Peptides Complexed To Hla-B2705" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 139 no PDB 2BST . "Crystal Structures And Kir3dl1 Recognition Of Three Immunodominant Viral Peptides Complexed To Hla-b2705" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 140 no PDB 2BVO . "Structures Of Three Hiv-1 Hla-B5703-Peptide Complexes And Identification Of Related Hlas Potentially Associated With Long-Term " . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 141 no PDB 2BVP . "Structures Of Three Hiv-1 Hla-B5703-Peptide Complexes And Identification Of Related Hlas Potentially Associated With Long-Term " . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 142 no PDB 2BVQ . "Structures Of Three Hiv-1 Hla-B5703-Peptide Complexes And Identification Of Related Hlas Potentially Associated With Long-Term " . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 143 no PDB 2C7U . "Conflicting Selective Forces Affect Cd8 T-Cell Receptor Contact Sites In An Hla-A2 Immunodominant Hiv Epitope." . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 144 no PDB 2CII . "The Crystal Structure Of H-2db Complexed With A Partial Peptide Epitope Suggests An Mhc Class I Assembly- Intermediate" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 145 no PDB 2CIK . "Insights Into Crossreactivity In Human Allorecognition: The Structure Of Hla-B35011 Presenting An Epitope Derived From Cytochro" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 146 no PDB 2CLR . "Three Dimensional Structure Of A Peptide Extending Out One End Of A Class I Mhc Binding Site" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 147 no PDB 2D31 . "Crystal Structure Of Disulfide-Linked Hla-G Dimer" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 148 no PDB 2D4D . "The Crystal Structure Of Human Beta2-Microglobulin, L39w W60f W95f Mutant" . . . . . 100.00 100 97.00 98.00 2.40e-64 . . . . 16587 1 149 no PDB 2D4F . "The Crystal Structure Of Human Beta2-Microglobulin" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 150 no PDB 2DYP . "Crystal Structure Of Lilrb2(Lir2ILT4CD85D) COMPLEXED WITH Hla-G" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 151 no PDB 2ESV . "Structure Of The Hla-E-VmaprtlilKK50.4 TCR COMPLEX" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 152 no PDB 2F53 . "Directed Evolution Of Human T-Cell Receptor Cdr2 Residues By Phage Display Dramatically Enhances Affinity For Cognate Peptide-M" . . . . . 100.00 100 98.00 98.00 9.83e-66 . . . . 16587 1 153 no PDB 2F54 . "Directed Evolution Of Human T Cell Receptor Cdr2 Residues By Phage Display Dramatically Enhances Affinity For Cognate Peptide-M" . . . . . 100.00 100 97.00 97.00 2.06e-64 . . . . 16587 1 154 no PDB 2F74 . "Murine Mhc Class I H-2db In Complex With Human B2-Microglobulin And Lcmv-Derived Immunodminant Peptide Gp33" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 155 no PDB 2F8O . "A Native To Amyloidogenic Transition Regulated By A Backbone Trigger" . . . . . 100.00 100 98.00 98.00 4.53e-66 . . . . 16587 1 156 no PDB 2FYY . "The Role Of T Cell Receptor Alpha Genes In Directing Human Mhc Restriction" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 157 no PDB 2FZ3 . "The Role Of T Cell Receptor Alpha Genes In Directing Human Mhc Restriction" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 158 no PDB 2GIT . "Human Class I Mhc Hla-A2 In Complex With The Modified Htlv-1 Tax (Y5k- 4-[3-Indolyl]-Butyric Acid) Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 159 no PDB 2GJ6 . "The Complex Between Tcr A6 And Human Class I Mhc Hla-a2 With The Modified Htlv-1 Tax (y5k-4-[3-indolyl]-butyric Acid) Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 160 no PDB 2GT9 . "Human Class I Mhc Hla-A2 In Complex With The Decameric Melan-AMART- 1(26-35) Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 161 no PDB 2GTW . "Human Class I Mhc Hla-A2 In Complex With The Nonameric Melan-AMART- 1(27-35) Peptide Having A27l Substitution" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 162 no PDB 2GTZ . "Human Class I Mhc Hla-A2 In Complex With The Nonameric Melan-AMART- 1(27-35) Peptide Having A28l Substitution" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 163 no PDB 2GUO . "Human Class I Mhc Hla-A2 In Complex With The Native Nonameric Melan- AMART-1(27-35) Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 164 no PDB 2H26 . "Human Cd1b In Complex With Endogenous Phosphatidylcholine And Spacer" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 165 no PDB 2H6P . "Crystal Structure Of Hla-B3501 Presenting The Human Cytochrome P450 Derived Peptide, Kpivvlhgy" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 166 no PDB 2HJK . "Crystal Structure Of Hla-B5703 And Hiv-1 Peptide" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 167 no PDB 2HJL . "Crystal Structure Of Hla-B5703 And Hiv-1 Peptide" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 168 no PDB 2HLA . "Specificity Pockets For The Side Chains Of Peptide Antigens In Hla-Aw68" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 169 no PDB 2HN7 . "Hla-A1101 In Complex With Hbv Peptide Homologue" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 170 no PDB 2J8U . "Large Cdr3a Loop Alteration As A Function Of Mhc Mutation." . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 171 no PDB 2JCC . "Ah3 Recognition Of Mutant Hla-A2 W167a" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 172 no PDB 2NW3 . "Crystal Structure Of Hla-B3508 Presenting Ebv Peptide Eplpqgqltay At 1.7a" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 173 no PDB 2NX5 . "Crystal Structure Of Els4 Tcr Bound To Hla-B3501 Presenting Peptide Eplpqgqltay At 1.7a" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 174 no PDB 2P5E . "Crystal Structures Of High Affinity Human T-Cell Receptors Bound To Pmhc Reveal Native Diagonal Binding Geometry" . . . . . 100.00 100 98.00 98.00 9.83e-66 . . . . 16587 1 175 no PDB 2P5W . "Crystal Structures Of High Affinity Human T-Cell Receptors Bound To Pmhc Reveal Native Diagonal Binding Geometry" . . . . . 100.00 100 98.00 98.00 9.83e-66 . . . . 16587 1 176 no PDB 2PO6 . "Crystal Structure Of Cd1d-lipid-antigen Complexed With Beta-2- Microglobulin, Nkt15 Alpha-chain And Nkt15 Beta-chain" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 177 no PDB 2PYE . "Crystal Structures Of High Affinity Human T-Cell Receptors Bound To Pmhc Revealnative Diagonal Binding Geometry Tcr Clone C5c1 " . . . . . 100.00 100 98.00 98.00 9.83e-66 . . . . 16587 1 178 no PDB 2RFX . "Crystal Structure Of Hla-B5701, Presenting The Self Peptide, Lsspvtksf" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 179 no PDB 2UWE . "Large Cdr3a Loop Alteration As A Function Of Mhc Mutation" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 180 no PDB 2V2W . "T Cell Cross-Reactivity And Conformational Changes During Tcr Engagement" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 181 no PDB 2V2X . "T Cell Cross-Reactivity And Conformational Changes During Tcr Engagement." . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 182 no PDB 2VB5 . "Solution Structure Of W60g Mutant Of Human Beta2- Microglobulin" . . . . . 100.00 100 100.00 100.00 3.13e-68 . . . . 16587 1 183 no PDB 2VLJ . "The Structural Dynamics And Energetics Of An Immunodominant T-Cell Receptor Are Programmed By Its Vbeta Domain" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 184 no PDB 2VLK . "The Structural Dynamics And Energetics Of An Immunodominant T-Cell Receptor Are Programmed By Its Vbeta Domain" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 185 no PDB 2VLL . "The Structural Dynamics And Energetics Of An Immunodominant T-Cell Receptor Are Programmed By Its Vbeta Domain" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 186 no PDB 2VLR . "The Structural Dynamics And Energetics Of An Immunodominant T-cell Receptor Are Programmed By Its Vbeta Domain" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 187 no PDB 2X4N . "Crystal Structure Of Mhc Class I Hla-A2.1 Bound To Residual Fragments Of A Photocleavable Peptide That Is Cleaved Upon Uv-Light" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 188 no PDB 2X4O . "Crystal Structure Of Mhc Class I Hla-A2.1 Bound To Hiv-1 Envelope Peptide Env120-128" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 189 no PDB 2X4P . "Crystal Structure Of Mhc Class I Hla-A2.1 Bound To A Photocleavable Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 190 no PDB 2X4Q . "Crystal Structure Of Mhc Class I Hla-A2.1 Bound To A Photocleavable Peptide" . . . . . 98.00 100 98.98 98.98 7.00e-65 . . . . 16587 1 191 no PDB 2X4R . "Crystal Structure Of Mhc Class I Hla-A2.1 Bound To Cytomegalovirus (Cmv) Pp65 Epitope" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 192 no PDB 2X4S . "Crystal Structure Of Mhc Class I Hla-A2.1 Bound To A Peptide Representing The Epitope Of The H5n1 (Avian Flu) Nucleoprotein" . . . . . 98.00 100 98.98 98.98 7.00e-65 . . . . 16587 1 193 no PDB 2X4T . "Crystal Structure Of Mhc Class I Hla-A2.1 Bound To A Peiodate-Cleavable Peptide" . . . . . 98.00 100 98.98 98.98 7.00e-65 . . . . 16587 1 194 no PDB 2X4U . "Crystal Structure Of Mhc Class I Hla-A2.1 Bound To Hiv-1 Peptide Rt468-476" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 195 no PDB 2X70 . "Crystal Structure Of Mhc Class I Hla-A2.1 Bound To A Photocleavable Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 196 no PDB 2X89 . "Structure Of The Beta2_microglobulin Involved In Amyloidogenesis" . . . . . 93.00 94 98.92 98.92 3.63e-61 . . . . 16587 1 197 no PDB 2XKS . "Prion-Like Conversion During Amyloid Formation At Atomic Resolution" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 198 no PDB 2XKU . "Prion-Like Conversion During Amyloid Formation At Atomic Resolution" . . . . . 93.00 94 98.92 98.92 3.63e-61 . . . . 16587 1 199 no PDB 2XPG . "Crystal Structure Of A Mhc Class I-Peptide Complex" . . . . . 97.00 98 98.97 98.97 2.84e-64 . . . . 16587 1 200 no PDB 2YPK . "Structural Features Underlying T-cell Receptor Sensitivity To Concealed Mhc Class I Micropolymorphisms" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 201 no PDB 2YPL . "Structural Features Underlying T-cell Receptor Sensitivity To Concealed Mhc Class I Micropolymorphisms" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 202 no PDB 2YXF . "The High Resolution Crystal Structure Of Beta2- Microglobulin Under Physiological Conditions" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 203 no PDB 2Z9T . "Crystal Structure Of The Human Beta-2 Microglobulin Mutant W60g" . . . . . 100.00 100 100.00 100.00 3.13e-68 . . . . 16587 1 204 no PDB 3AM8 . "Crystal Structure Of A Human Major Histocompatibilty Complex" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 205 no PDB 3B3I . "Citrullination-dependent Differential Presentation Of A Self-peptide By Hla-b27 Subtypes" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 206 no PDB 3B6S . "Crystal Structure Of Hla-B2705 Complexed With The Citrullinated Vasoactive Intestinal Peptide Type 1 Receptor (Vipr) Peptide (R" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 207 no PDB 3BGM . "Crystal Structure Of Pkd2 Phosphopeptide Bound To Human Class I Mhc Hla-A2" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 208 no PDB 3BH8 . "Crystal Structure Of Rqa_m Phosphopeptide Bound To Human Class I Mhc Hla-A2" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 209 no PDB 3BH9 . "Crystal Structure Of Rty Phosphopeptide Bound To Human Class I Mhc Hla-A2" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 210 no PDB 3BHB . "Crystal Structure Of Kmd Phosphopeptide Bound To Human Class I Mhc Hla-A2" . . . . . 98.00 98 98.98 98.98 3.46e-65 . . . . 16587 1 211 no PDB 3BO8 . "The High Resolution Crystal Structure Of Hla-A1 Complexed With The Mage-A1 Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 212 no PDB 3BP4 . "The High Resolution Crystal Structure Of Hla-B2705 In Complex With A Cathepsin A Signal Sequence Peptide Pcata" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 213 no PDB 3BP7 . "The High Resolution Crystal Structure Of Hla-b*2709 In Complex With A Cathepsin A Signal Sequence Peptide, Pcata" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 214 no PDB 3BVN . "High Resolution Crystal Structure Of Hla-B1402 In Complex With The Latent Membrane Protein 2 Peptide (Lmp2) Of Epstein-Barr Vir" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 215 no PDB 3BW9 . "Crystal Structure Of Hla B3508 In Complex With A Hcmv 12- Mer Peptide From The Pp65 Protein" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 216 no PDB 3BWA . "Crystal Structure Of Hla B3508 In Complex With A Hcmv 8- Mer Peptide From The Pp65 Protein" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 217 no PDB 3BXN . "The High Resolution Crystal Structure Of Hla-b*1402 Complexed With A Cathepsin A Signal Sequence Peptide, Pcata" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 218 no PDB 3BZE . "The Human Non-Classical Major Histocompatibility Complex Molecule Hla- E" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 219 no PDB 3BZF . "The Human Non-Classical Major Histocompatibility Complex Molecule Hla-E" . . . . . 97.00 97 98.97 98.97 2.31e-64 . . . . 16587 1 220 no PDB 3C9N . "Crystal Structure Of A Sars Corona Virus Derived Peptide Bound To The Human Major Histocompatibility Complex Class I Molecule H" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 221 no PDB 3CDG . "Human Cd94NKG2A IN COMPLEX WITH HLA-E" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 222 no PDB 3CII . "Structure Of Nkg2aCD94 BOUND TO HLA-E" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 223 no PDB 3CIQ . "A Regulatable Switch Mediates Self-Association In An Immunoglobulin Fold" . . . . . 100.00 100 98.00 98.00 1.25e-65 . . . . 16587 1 224 no PDB 3CZF . "Crystal Structure Of Hla-B2709 Complexed With The Glucagon Receptor (Gr) Peptide (Residues 412-420)" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 225 no PDB 3D18 . "Crystal Structure Of Hla-B2709 Complexed With A Variant Of The Latent Membrane Protein 2 Peptide (Lmp2(L)) Of Epstein-Barr Viru" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 226 no PDB 3D25 . "Crystal Structure Of Ha-1 Minor Histocompatibility Antigen Bound To Human Class I Mhc Hla-A2" . . . . . 98.00 98 98.98 98.98 3.46e-65 . . . . 16587 1 227 no PDB 3D2U . "Structure Of Ul18, A Peptide-binding Viral Mhc Mimic, Bound To A Host Inhibitory Receptor" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 228 no PDB 3D39 . "The Complex Between Tcr A6 And Human Class I Mhc Hla-A2 With The Modified Htlv-1 Tax (Y5(4-Fluorophenylalanine)) Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 229 no PDB 3D3V . "The Complex Between Tcr A6 And Human Class I Mhc Hla-a2 With The Modified Htlv-1 Tax (y5(3,4-difluorophenylalanine)) Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 230 no PDB 3DBX . "Structure Of Chicken Cd1-2 With Bound Fatty Acid" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 231 no PDB 3DHJ . "Beta 2 Microglobulin Mutant W60c" . . . . . 100.00 100 99.00 99.00 6.36e-67 . . . . 16587 1 232 no PDB 3DHM . "Beta 2 Microglobulin Mutant D59p" . . . . . 100.00 100 98.00 98.00 9.11e-66 . . . . 16587 1 233 no PDB 3DTX . "Crystal Structure Of Hla-B2705 Complexed With The Double Citrullinated Vasoactive Intestinal Peptide Type 1 Receptor (Vipr) Pep" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 234 no PDB 3DX6 . "Crystal Structure Of B4402 Presenting A 10mer Ebv Epitope" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 235 no PDB 3DX7 . "Crystal Structure Of Hla-B4403 Presenting 10mer Ebv Antigen" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 236 no PDB 3DX8 . "Crystal Structure Of B4405 Presenting A 10mer Ebv Epitope" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 237 no PDB 3DXA . "Crystal Structure Of The Dm1 Tcr In Complex With Hla-B4405 And Decamer Ebv Antigen" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 238 no PDB 3EKC . "Structure Of W60v Beta-2 Microglobulin Mutant" . . . . . 100.00 100 99.00 99.00 5.23e-67 . . . . 16587 1 239 no PDB 3FFC . "Crystal Structure Of Cf34 Tcr In Complex With Hla-b8/flr" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 240 no PDB 3FQN . "Phosphorylation Of Self-Peptides Alters Human Leukocyte Antigen Class I-Restricted Antigen Presentation And Generates Tumor Spe" . . . . . 98.00 98 98.98 98.98 3.46e-65 . . . . 16587 1 241 no PDB 3FQR . "Phosphorylation Of Self-Peptides Alters Human Leukocyte Antigen Class I-Restricted Antigen Presentation And Generates Tumor Spe" . . . . . 98.00 98 98.98 98.98 3.46e-65 . . . . 16587 1 242 no PDB 3FQT . "Phosphorylation Of Self-Peptides Alters Human Leukocyte Antigen Class I-Restricted Antigen Presentation And Generates Tumor Spe" . . . . . 98.00 98 98.98 98.98 3.46e-65 . . . . 16587 1 243 no PDB 3FQU . "Phosphorylation Of Self-Peptides Alters Human Leukocyte Antigen Class I-Restricted Antigen Presentation And Generates Tumor Spe" . . . . . 98.00 98 98.98 98.98 3.46e-65 . . . . 16587 1 244 no PDB 3FQW . "Phosphorylation Of Self-Peptides Alters Human Leukocyte Antigen Class I-Restricted Antigen Presentation And Generates Tumor Spe" . . . . . 98.00 98 98.98 98.98 3.46e-65 . . . . 16587 1 245 no PDB 3FQX . "Phosphorylation Of Self-Peptides Alters Human Leukocyte Antigen Class I-Restricted Antigen Presentation And Generates Tumor Spe" . . . . . 98.00 98 98.98 98.98 3.46e-65 . . . . 16587 1 246 no PDB 3FT2 . "Crystal Structure Of A Citrulline Peptide Variant Of The Minor Histocompatibility Peptide Ha-1 In Complex With Hla- A2" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 247 no PDB 3FT3 . "Crystal Structure Of The Minor Histocompatibility Peptide Ha-1his In Complex With Hla-A2" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 248 no PDB 3FT4 . "Crystal Structure Of The Minor Histocompatibility Peptide Ha-1arg In Complex With Hla-A2" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 249 no PDB 3GIV . "Antigen Processing Influences Hiv-Specific Cytotoxic T Lymphocyte Immunodominance" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 250 no PDB 3GJF . "Rational Development Of High-Affinity T-Cell Receptor-Like Antibodies" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 251 no PDB 3GSN . "Crystal Structure Of The Public Ra14 Tcr In Complex With The Hcmv Dominant NlvHLA-A2 Epitope" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 252 no PDB 3GSO . "Crystal Structure Of The Binary Complex Between Hla-A2 And Hcmv Nlv Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 253 no PDB 3GSQ . "Crystal Structure Of The Binary Complex Between Hla-A2 And Hcmv Nlv-M5s Peptide Variant" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 254 no PDB 3GSR . "Crystal Structure Of The Binary Complex Between Hla-A2 And Hcmv Nlv-M5v Peptide Variant" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 255 no PDB 3GSU . "Crystal Structure Of The Binary Complex Between Hla-A2 And Hcmv Nlv-M5t Peptide Variant" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 256 no PDB 3GSV . "Crystal Structure Of The Binary Complex Between Hla-A2 And Hcmv Nlv-M5q Peptide Variant" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 257 no PDB 3GSW . "Crystal Structure Of The Binary Complex Between Hla-A2 And Hcmv Nlv-T8a Peptide Variant" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 258 no PDB 3GSX . "Crystal Structure Of The Binary Complex Between Hla-A2 And Hcmv Nlv-T8v Peptide Variant" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 259 no PDB 3H7B . "Human Class I Mhc Hla-a2 In Complex With The Tel1p Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 260 no PDB 3H9H . "Human Class I Mhc Hla-A2(A150p) In Complex With The Tel1p Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 261 no PDB 3H9S . "The Complex Between Tcr A6 And Human Class I Mhc Hla-A2 With The Bound Tel1p Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 262 no PDB 3HAE . "Rational Development Of High-Affinity T-Cell Receptor-Like Antibodies" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 263 no PDB 3HCV . "Crystal Structure Of Hla-B2709 Complexed With The Double Citrullinated Vasoactive Intestinal Peptide Type 1 Receptor (Vipr) Pep" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 264 no PDB 3HG1 . "Germline-governed Recognition Of A Cancer Epitope By An Immunodominant Human T Cell Receptor" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 265 no PDB 3HLA . "Human Class I Histocompatibility Antigen A2.1" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 266 no PDB 3HPJ . "Human Class I Mhc Hla-a2 In Complex With The Wt-1 (126-134) Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 267 no PDB 3HUJ . "Crystal Structure Of Human Cd1d-Alpha-Galactosylceramide In Complex With Semi-Invariant Nkt Cell Receptor" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 268 no PDB 3I6G . "Newly Identified Epitope Mn2 From Sars-Cov M Protein Complexed Withhla-A0201" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 269 no PDB 3I6K . "Newly Identified Epitope From Sars-Cov Membrane Protein Complexed With Hla-A0201" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 270 no PDB 3I6L . "Newly Identified Epitope N1 Derived From Sars-Cov N Protein Complexed With Hla-A2402" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 271 no PDB 3IB4 . "The Double Mutant Of Beta-2 Microglobulin K58p-W60g" . . . . . 100.00 100 98.00 98.00 7.09e-66 . . . . 16587 1 272 no PDB 3IXA . "Human Class I Mhc Hla-A2(A150p) In Complex With The Tax Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 273 no PDB 3JTS . Gy9-Mamu-A02-Hb2m . . . . . 99.00 119 98.99 98.99 1.03e-66 . . . . 16587 1 274 no PDB 3KLA . "Ca2+ Release From The Endoplasmic Reticulum Of Ny-Eso-1 Specific T Cells Is Modulated By The Affinity Of T Cell Receptor And By" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 275 no PDB 3KPL . "Crystal Structure Of Hla B4402 In Complex With Eeylqafty A Self Peptide From The Abcd3 Protein" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 276 no PDB 3KPM . "Crystal Structure Of Hla B4402 In Complex With Eeylkawtf, A Mimotope" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 277 no PDB 3KPN . "Crystal Structure Of Hla B4403 In Complex With Eeylqafty A Self Peptide From The Abcd3 Protein" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 278 no PDB 3KPO . "Crystal Structure Of Hla B*4403 In Complex With Eeylkawtf, A Mimotope" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 279 no PDB 3KPP . "Crystal Structure Of Hla B4405 In Complex With Eeylqafty A Self Peptide From The Abcd3 Protein" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 280 no PDB 3KPQ . "Crystal Structure Of Hla B*4405 In Complex With Eeylkawtf, A Mimotope" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 281 no PDB 3KPR . "Crystal Structure Of The Lc13 Tcr In Complex With Hla B4405 Bound To Eeylkawtf A Mimotope" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 282 no PDB 3KPS . "Crystal Structure Of The Lc13 Tcr In Complex With Hla B4405 Bound To Eeylqafty A Self Peptide From The Abcd3 Protein" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 283 no PDB 3KWW . "Crystal Structure Of The 'restriction Triad' Mutant Of Hla B Beta-2-Microglobulin And Ebv Peptide" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 284 no PDB 3KXF . "Crystal Structure Of Sb27 Tcr In Complex With The 'restriction Triad' Mutant Hla-b*3508-13mer" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 285 no PDB 3KYN . "Crystal Structure Of Hla-g Presenting Kgppaaltl Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 286 no PDB 3KYO . "Crystal Structure Of Hla-g Presenting Klpaqfyil Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 287 no PDB 3L3D . "Crystal Structure Of Hla-b*4402 In Complex With The F3a Mutant Of A Self-peptide Derived From Dpa*0201" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 288 no PDB 3L3G . "Crystal Structure Of Hla-b*4402 In Complex With The R5a Mutant Of A Self-peptide Derived From Dpa*0201" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 289 no PDB 3L3I . "Crystal Structure Of Hla-b*4402 In Complex With The F7a Mutant Of A Self-peptide Derived From Dpa*0201" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 290 no PDB 3L3J . "Crystal Structure Of Hla-b*4402 In Complex With The F3a/r5a Double Mutant Of A Self-peptide Derived From Dpa*0201" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 291 no PDB 3L3K . "Crystal Structure Of Hla-b*4402 In Complex With The R5a/f7a Double Mutant Of A Self-peptide Derived From Dpa*0201" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 292 no PDB 3LKN . "Crystal Structure Of Hla B3501 In Complex With Influenza Np418 Epitope From 1918 Strain" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 293 no PDB 3LKO . "Crystal Structure Of Hla B3501 In Complex With Influenza Np418 Epitope From 1934 Strain" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 294 no PDB 3LKP . "Crystal Structure Of Hla B3501 In Complex With Influenza Np418 Epitope From 1972 Strain" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 295 no PDB 3LKQ . "Crystal Structure Of Hla B3501 In Complex With Influenza Np418 Epitope From 1977 Strain" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 296 no PDB 3LKR . "Crystal Structure Of Hla B3501 In Complex With Influenza Np418 Epitope From 2009 H1n1 Swine Origin Strain" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 297 no PDB 3LKS . "Crystal Structure Of Hla B3501 In Complex With Influenza Np418 Epitope From 1980 Strain" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 298 no PDB 3LN4 . "Crystal Structure Of Hla-B4103 In Complex With A 16mer Self-Peptide Derived From Heterogeneous Nuclear Ribonucleoproteins C1C2" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 299 no PDB 3LN5 . "Crystal Structure Of Hla-B4104 In Complex With A 11mer Self-Peptide Derived From S-Methyl-5-Thioadenosine Phosphorylase" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 300 no PDB 3LOW . "Crystal Structure Of Beta 2 Microglobulin Domain-Swapped Dimer" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 301 no PDB 3LV3 . "Crystal Structure Of Hla-B2705 Complexed With A Peptide Derived From The Human Voltage-Dependent Calcium Channel Alpha1 Subunit" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 302 no PDB 3M17 . "Crystal Structure Of Human Fcrn With A Monomeric Peptide Inhibitor" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 303 no PDB 3M1B . "Crystal Structure Of Human Fcrn With A Dimeric Peptide Inhibitor" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 304 no PDB 3MGO . "Crystal Structure Of A H5-Specific Ctl Epitope Derived From Influenza Virus In Complex With Hla-A0201" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 305 no PDB 3MGT . "Crystal Structure Of A H5-Specific Ctl Epitope Variant Deriv H5n1 Influenza Virus In Complex With Hla-A0201" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 306 no PDB 3MR9 . "Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed With Hcmv Pp65-495-503 Nonapeptide M5a Variant" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 307 no PDB 3MRB . "Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed With Hcmv Pp65-495-503 Nonapeptide A7h Variant" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 308 no PDB 3MRC . "Crystal Structure Of Mhc Class I Hla-a2 Molecule Complexed With Hcmv Pp65-495-503 Nonapeptide V6c Variant" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 309 no PDB 3MRD . "Crystal Structure Of Mhc Class I Hla-a2 Molecule Complexed With Hcmv Pp65-495-503 Nonapeptide V6g Variant" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 310 no PDB 3MRE . "Crystal Structure Of Mhc Class I Hla-a2 Molecule Complexed With Ebv Bmlf1-280-288 Nonapeptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 311 no PDB 3MRF . "Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed With Ebv Bmlf1-280-288 Nonapeptide T4p Variant" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 312 no PDB 3MRG . "Crystal Structure Of Mhc Class I Hla-a2 Molecule Complexed With Hcv Ns3-1073-1081 Nonapeptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 313 no PDB 3MRH . "Crystal Structure Of Mhc Class I Hla-a2 Molecule Complexed With Hcv Ns3-1073-1081 Nonapeptide N3s Variant" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 314 no PDB 3MRI . "Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed With Hcv Ns3-1073-1081 Nonapeptide G4m-V5w Variant" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 315 no PDB 3MRJ . "Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed With Hcv Ns3-1073-1081 Nonapeptide V5m Variant" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 316 no PDB 3MRK . "Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed With Afp137 Nonapeptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 317 no PDB 3MRL . "Crystal Structure Of Mhc Class I Hla-a2 Molecule Complexed With Hcv Ns3-1073-1081 Nonapeptide C6v Variant" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 318 no PDB 3MRM . "Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed With Hcv Ns3-1406-1415 Decapeptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 319 no PDB 3MRN . "Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed With Hcv Ns4b-1807-1816 Decapeptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 320 no PDB 3MRO . "Crystal Structure Of Mhc Class I Hla-a2 Molecule Complexed With Melan- A Mart1 Decapeptide Variant" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 321 no PDB 3MRP . "Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed With Melan- A Mart1 Decapeptide Variant" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 322 no PDB 3MRQ . "Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed With Melan- A Mart1 Decapeptide Variant" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 323 no PDB 3MRR . "Crystal Structure Of Mhc Class I Hla-a2 Molecule Complexed With Human Prostaglandin Transporter Decapeptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 324 no PDB 3MV7 . "Crystal Structure Of The Tk3 Tcr In Complex With Hla-B3501HPVG" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 325 no PDB 3MV8 . "Crystal Structure Of The Tk3-Gln55his Tcr In Complex With Hla- B3501HPVG" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 326 no PDB 3MV9 . "Crystal Structure Of The Tk3-Gln55ala Tcr In Complex With Hla- B3501HPVG" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 327 no PDB 3MYJ . "Human Class I Mhc Hla-a2 In Complex With The Wt-1 (126-134) (r1y) Peptide Variant." . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 328 no PDB 3MYZ . "Protein Induced Photophysical Changes To The Amyloid Indicator Dye, Thioflavin T" . . . . . 100.00 100 98.00 98.00 1.25e-65 . . . . 16587 1 329 no PDB 3MZT . "Protein-Induced Photophysical Changes To The Amyloid Indicator Dye, Thioflavin T" . . . . . 100.00 100 98.00 98.00 1.25e-65 . . . . 16587 1 330 no PDB 3NA4 . "D53p Beta-2 Microglobulin Mutant" . . . . . 100.00 100 97.00 97.00 2.43e-64 . . . . 16587 1 331 no PDB 3NFN . "Recognition Of Peptide-mhc By A V-delta/v-beta Tcr" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 332 no PDB 3O3A . "Human Class I Mhc Hla-A2 In Complex With The Peptidomimetic Ela-1" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 333 no PDB 3O3B . "Human Class I Mhc Hla-A2 In Complex With The Peptidomimetic Ela-1.1" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 334 no PDB 3O3D . "Human Class I Mhc Hla-A2 In Complex With The Peptidomimetic Ela-2" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 335 no PDB 3O3E . "Human Class I Mhc Hla-A2 In Complex With The Peptidomimetic Ela-2.1" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 336 no PDB 3O4L . "Genetic And Structural Basis For Selection Of A Ubiquitous T Cell Receptor Deployed In Epstein-barr Virus" . . . . . 100.00 100 98.00 98.00 9.83e-66 . . . . 16587 1 337 no PDB 3OX8 . "Crystal Structure Of Hla A02:03 Bound To Hbv Core 18-27" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 338 no PDB 3OXR . "Crystal Structure Of Hla A02:06 Bound To Hbv Core 18-27" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 339 no PDB 3OXS . "Crystal Structure Of Hla A02:07 Bound To Hbv Core 18-27" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 340 no PDB 3PWJ . "Human Class I Mhc Hla-A2 In Complex With The Hud (G2l,I9v) Peptide Variant" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 341 no PDB 3PWL . "Human Class I Mhc Hla-A2 In Complex With The Hud Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 342 no PDB 3PWN . "Human Class I Mhc Hla-A2 In Complex With The Hud (G2l) Peptide Variant" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 343 no PDB 3PWP . "The Complex Between Tcr A6 And Human Class I Mhc Hla-A2 With The Bound Hud Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 344 no PDB 3QDA . "Crystal Structure Of W95l Beta-2 Microglobulin" . . . . . 100.00 100 98.00 98.00 3.26e-65 . . . . 16587 1 345 no PDB 3QDG . "The Complex Between Tcr Dmf5 And Human Class I Mhc Hla-A2 With The Bound Mart-1(26-35)(A27l) Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 346 no PDB 3QDJ . "The Complex Between Tcr Dmf5 And Human Class I Mhc Hla-A2 With The Bound Mart-1(27-35) Nonameric Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 347 no PDB 3QDM . "The Complex Between Tcr Dmf4 And Human Class I Mhc Hla-A2 With The Bound Mart-1(26-35)(A27l) Decameric Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 348 no PDB 3QEQ . "The Complex Between Tcr Dmf4 And Human Class I Mhc Hla-A2 With The Bound Mart-1(27-35) Nonameric Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 349 no PDB 3QFD . "Human Class I Mhc Hla-A2 In Complex With Mart-1(27-35) Nonameric Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 350 no PDB 3QFJ . "The Complex Between Tcr A6 And Human Class I Mhc Hla-A2 With The Modified Tax (Y5f) Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 351 no PDB 3QZW . "Plasticity Of Human Cd8 Binding To Peptide-hla-a*2402" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 352 no PDB 3REW . "Crystal Structure Of An Lmp2a-Derived Peptide Bound To Human Class I Mhc Hla-A2" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 353 no PDB 3RL1 . "Hiv Rt Derived Peptide Complexed To Hla-A0301" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 354 no PDB 3RL2 . "Hiv Nef Derived Peptide Nef73 Complexed To Hla-A0301" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 355 no PDB 3RWJ . "Rhesus Macaque Mhc Class I Molecule Mamu-B17-Hw8" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 356 no PDB 3SDX . "Crystal Structure Of Human Autoreactive-Valpha24 Nkt Tcr In Complex With Cd1d-Beta-Galactosylceramide" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 357 no PDB 3SJV . "Crystal Structure Of The Rl42 Tcr In Complex With Hla-B8-Flr" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 358 no PDB 3SKM . "Crystal Structure Of The Hla-B8flrgrayvl, Mutant G8v Of The Flr Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 359 no PDB 3SKO . "Crystal Structure Of The Hla-B8-A66-Flr, Mutant A66 Of The Hla B8" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 360 no PDB 3SPV . "Crystal Structure Of A Peptide-Hla Complex" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 361 no PDB 3T8X . "Crystal Structure Of Human Cd1b In Complex With Synthetic Antigenic Diacylsulfoglycolipid Sgl12 And Endogenous Spacer" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 362 no PDB 3TID . "Crystal Structure Of The Lcmv Derived Peptide Gp34 In Complex With The Murine Mhc Class I H-2 Kb" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 363 no PDB 3TIE . "Crystal Structure Of The Vaccinia Derived Peptide A11r In Complex With The Murine Mhc Class I H-2 Kb" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 364 no PDB 3TLR . "Crystal Structure Of The Tetrameric Beta-2 Microglobulin Dimc20 Mutant" . . . . . 100.00 100 98.00 98.00 4.20e-66 . . . . 16587 1 365 no PDB 3TM6 . "Crystal Structure Of The Beta-2 Microglobulin Dimc50 Disulphide-linked Homodimer Mutant" . . . . . 100.00 100 98.00 98.00 1.36e-65 . . . . 16587 1 366 no PDB 3TO2 . "Structure Of Hla-A0201 Complexed With Peptide Md3-C9 Derived From A Clustering Region Of Restricted Cytotoxic T Lymphocyte Epit" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 367 no PDB 3TZV . "Crystal Structure Of An Inkt Tcr In Complex With Cd1d- Lysophosphatidylcholine" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 368 no PDB 3U0P . "Crystal Structure Of Human Cd1d-Lysophosphatidylcholine" . . . . . 99.00 102 98.99 98.99 7.13e-66 . . . . 16587 1 369 no PDB 3UPR . "Hla-B57:01 Complexed To Pep-V And Abacavir" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 370 no PDB 3UTQ . "Human Hla-A0201-Alwgpdpaaa" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 371 no PDB 3UTS . "1e6-A0201-Alwgpdpaaa Complex, Monoclinic" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 372 no PDB 3UTT . "1e6-A0201-Alwgpdpaaa Complex, Triclinic" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 373 no PDB 3V5D . "Hla-A2.1 Kvaelvhfl" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 374 no PDB 3V5H . "Hla-A2.1 Kvaeivhfl" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 375 no PDB 3V5K . "Hla2.1 Kvaelvwfl" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 376 no PDB 3VCL . "Crystal Structure Of Hla-B7 With The Hcmv Pp65 Peptide Rpherngftvl" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 377 no PDB 3VFM . "Crystal Structure Of Hla B3508 Lpep155a, Hla Mutant Ala155" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 378 no PDB 3VFN . "Crystal Structure Of Hla B3508lpep151a, Hla Mutant Ala151" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 379 no PDB 3VFO . "Crystal Structure Of Hla B3508 Lpep157a, Hla Mutant Ala157" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 380 no PDB 3VFP . "Crystal Structure Of Hla B3508 Lpep158g, Hla Mutant Gly158" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 381 no PDB 3VFR . "Crystal Structure Of Hla B3508lpep-P4ala, Peptide Mutant P4-Ala" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 382 no PDB 3VFS . "Crystal Structure Of Hla B3508lpep-P5ala , Peptide Mutant P5-Ala" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 383 no PDB 3VFT . "Crystal Structure Of Hla B3508lpep-P6ala, Peptide Mutant P6-Ala" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 384 no PDB 3VFU . "Crystal Structure Of Hla B3508 Lpep-P7ala, Peptide Mutant P7-Ala" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 385 no PDB 3VFV . "Crystal Structure Of Hla B3508 Lpep-P9ala, Peptide Mutant P9-Ala" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 386 no PDB 3VFW . "Crystal Structure Of Hla B3508 Lpep-P10ala, Peptide Mutant P10-Ala" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 387 no PDB 3VH8 . "Kir3dl1 In Complex With Hla-B5701" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 388 no PDB 3VRI . "Hla-B57:01-Rvaqlenvyi In Complex With Abacavir" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 389 no PDB 3VRJ . "Hla-B57:01-Lttkltntni In Complex With Abacavir" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 390 no PDB 3VWJ . "Ternary Crystal Structure Of The Human Nkt Tcr-cd1d-c20:2 Complex" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 391 no PDB 3VWK . "Ternary Crystal Structure Of The Human Nkt Tcr-cd1d-4'deoxy-alpha- Galactosylceramide Complex" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 392 no PDB 3VXM . "The Complex Between C1-28 Tcr And Hla-a24 Bound To Hiv-1 Nef134-10(2f) Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 393 no PDB 3VXN . "Hla-a24 In Complex With Hiv-1 Nef134-10(wt)" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 394 no PDB 3VXO . "Hla-a24 In Complex With Hiv-1 Nef134-10(2f)" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 395 no PDB 3VXP . "Hla-a24 In Complex With Hiv-1 Nef134-10(6l)" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 396 no PDB 3VXR . "The Complex Between H27-14 Tcr And Hla-a24 Bound To Hiv-1 Nef134- 10(wt) Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 397 no PDB 3VXS . "The Complex Between H27-14 Tcr And Hla-a24 Bound To Hiv-1 Nef134- 10(6l) Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 398 no PDB 3VXU . "The Complex Between T36-5 Tcr And Hla-a24 Bound To Hiv-1 Nef134-10(2f) Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 399 no PDB 3W0W . "The Complex Between T36-5 Tcr And Hla-a24 Bound To Hiv-1 Nef134-10(2f) Peptide In Space Group P212121" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 400 no PDB 3W39 . "Crystal Structure Of Hla-b*5201 In Complexed With Hiv Immunodominant Epitope (taftipsi)" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 401 no PDB 3WL9 . "Hla-a24 In Complex With Hiv-1 Nef126-10(8i10f)" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 402 no PDB 3WLB . "Hla-a24 In Complex With Hiv-1 Nef126-10(8t10f)" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 403 no PDB 3WUW . "Kir3dl1 In Complex With Hla-b*57:01.i80t" . . . . . 98.00 98 98.98 98.98 3.46e-65 . . . . 16587 1 404 no PDB 4E5X . "Crystal Structure Of A Complex Between The Human Adenovirus Type 2 E3- 19k Protein And Mhc Class I Molecule Hla-A2TAX" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 405 no PDB 4EN3 . "Crystal Structure Of A Human Valpha24(-) Nkt Tcr In Complex With Cd1d/alpha-galactosylceramide" . . . . . 99.00 100 98.99 98.99 7.32e-66 . . . . 16587 1 406 no PDB 4EUP . "The Complex Between Tcr Jkf6 And Human Class I Mhc Hla-a2 Presenting The Mart-1(27-35)(a27l) Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 407 no PDB 4F7M . "Crystal Structure Of Hla-A2402 Complexed With A Newly Identified Peptide From 2009 H1n1 Pa (649-658)" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 408 no PDB 4F7P . "Crystal Structure Of Hla-a*2402 Complexed With A Newly Identified Peptide From 2009h1n1 Pb1 (496-505)" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 409 no PDB 4F7T . "Crystal Structure Of Hla-A2402 Complexed With A Newly Identified Peptide From 2009 H1n1 Pb1 (498-505)" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 410 no PDB 4FTV . "The Complex Between The High Affinity Version Of A6 Tcr (a6c134) And Human Class I Mhc Hla-a2 With The Bound Tax Nonameric Pept" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 411 no PDB 4FXL . "Crystal Structure Of The D76n Beta-2 Microglobulin Mutant" . . . . . 100.00 100 98.00 99.00 2.74e-66 . . . . 16587 1 412 no PDB 4G8G . "Crystal Structure Of C12c Tcr-ha B2705-kk10" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 413 no PDB 4G8I . "Crystal Structure Of Hla B2705-kk10-l6m" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 414 no PDB 4G9D . "Crystal Structure Of Hla B2705-kk10" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 415 no PDB 4G9F . "Crystal Structure Of C12c Tcr-hlab2705-kk10-l6m" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 416 no PDB 4GKN . "A2-Mhc Complex Carrying Fatgigiitv" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 417 no PDB 4GKS . "A2-Mhc Complex Carrying Fltgigiitv" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 418 no PDB 4GUP . "Structure Of Mhc-Class I Related Molecule Mr1" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 419 no PDB 4HKJ . "Structure Of Cowpox Cpxv203 In Complex With Mhci (H-2kb)" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 420 no PDB 4HWZ . "Structure Of Hla-a68 Complexed With An Hiv Derived Peptide" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 421 no PDB 4HX1 . "Structure Of Hla-a68 Complexed With A Tumor Antigen Derived Peptide" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 422 no PDB 4I48 . "Structure Of Hla-a68 Complexed With An Hiv Env Derived Peptide" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 423 no PDB 4I4W . "Peptide Length Determines The Outcome Of T Cell Receptor/peptide-mhci Engagement" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 424 no PDB 4JFD . "Preservation Of Peptide Specificity During Tcr-mhc Contact Dominated Affinity Enhancement Of A Melanoma-specific Tcr" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 425 no PDB 4JFE . "Preservation Of Peptide Specificity During Tcr-mhc Contact Dominated Affinity Enhancement Of A Melanoma-specific Tcr" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 426 no PDB 4JFF . "Preservation Of Peptide Specificity During Tcr-mhc Contact Dominated Affinity Enhancement Of A Melanoma-specific Tcr" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 427 no PDB 4JFO . "A2 Hla Complex With E1a Heteroclitic Variant Of Melanoma Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 428 no PDB 4JFP . "A2 Hla Complex With G4a Heteroclitic Variant Of Melanoma Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 429 no PDB 4JFQ . "A2 Hla Complex With L8a Heteroclitic Variant Of Melanoma Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 430 no PDB 4JQV . "Hla-b*18:01 In Complex With Epstein-barr Virus Bzlf1-derived Peptide (residues 173-180)" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 431 no PDB 4JQX . "Hla-b*44:03 In Complex With Epstein-barr Virus Bzlf1-derived Peptide (residues 169-180)" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 432 no PDB 4JRX . "Crystal Structure Of Ca5 Tcr-hla B*3505-lpep Complex" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 433 no PDB 4JRY . "Crystal Structure Of Sb47 Tcr-hla B*3505-lpep Complex" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 434 no PDB 4K71 . "Crystal Structure Of A High Affinity Human Serum Albumin Variant Bound To The Neonatal Fc Receptor" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 435 no PDB 4K7F . "Newly Identified Epitope V60 From Hbv Core Protein Complexed With Hla- A*0201" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 436 no PDB 4KDT . "Structure Of An Early Native-like Intermediate Of Beta2-microglobulin Amyloidosis" . . . . . 100.00 100 98.00 98.00 1.33e-65 . . . . 16587 1 437 no PDB 4L29 . "Structure Of Wtmhc Class I With Ny-eso1 Double Mutant" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 438 no PDB 4L3C . "Structure Of Hla-a2 In Complex With D76n B2m Mutant And Ny-eso1 Double Mutant" . . . . . 100.00 100 98.00 99.00 2.74e-66 . . . . 16587 1 439 no PDB 4L3E . "The Complex Between High Affinity Tcr Dmf5(alpha-d26y,beta-l98w) And Human Class I Mhc Hla-a2 With The Bound Mart-1(26-35)(a27l" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 440 no PDB 4L4T . "Structure Of Human Mait Tcr In Complex With Human Mr1-6-fp" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 441 no PDB 4L4V . "Structure Of Human Mait Tcr In Complex With Human Mr1-rl-6-me-7-oh" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 442 no PDB 4LCW . "The Structure Of Human Mait Tcr In Complex With Mr1-k43a-rl-6-me-7oh" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 443 no PDB 4LCY . "Crystal Structure Of Hla-b46 At 1.6 Angstrom Resolution" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 444 no PDB 4LHU . "Crystal Structure Of 9c2 Tcr Bound To Cd1d" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 445 no PDB 4LNR . "The Structure Of Hla-b*35:01 In Complex With The Peptide (rpqvplrpmty)" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 446 no PDB 4M8V . "Crystal Structure Of Human Double Mutant Beta2-microglobulin Q8h-l65t" . . . . . 100.00 100 97.00 97.00 3.02e-65 . . . . 16587 1 447 no PDB 4MJ5 . "Hla-a11 Complexed With A Pepitde" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 448 no PDB 4MJ6 . "Hla-a11 Complexed With A Mutated Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 449 no PDB 4MJI . "T Cell Response To A Hiv Reverse Transcriptase Epitope Presented By The Protective Allele Hla-b*51:01" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 450 no PDB 4MNQ . "Tcr-peptide Specificity Overrides Affinity Enhancing Tcr-mhc Interactions" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 451 no PDB 4N0F . "Human Fcrn Complexed With Human Serum Albumin" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 452 no PDB 4N0U . "Ternary Complex Between Neonatal Fc Receptor, Serum Albumin And Fc" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 453 no PDB 4N8V . "Crystal Structure Of Killer Cell Immunoglobulin-like Receptor Kir2ds2 In Complex With Hla-a" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 454 no PDB 4NNX . "Crystal Structure Of Pkd2 Phosphopeptide Bound To Hla-a2" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 455 no PDB 4NNY . "Crystal Structure Of Non-phosphorylated Form Of Pkd2 Phosphopeptide Bound To Hla-a2" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 456 no PDB 4NO0 . "Crystal Structure Of Non-phosphorylated Form Of Rqa_v Phosphopeptide Bound To Hla-a2 In Complex With Lilrb1" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 457 no PDB 4NO2 . "Crystal Structure Of Rqa_v Phosphopeptide Bound To Hla-a2" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 458 no PDB 4NQC . "Crystal Structure Of Tcr-mr1 Ternary Complex And Covalently Bound 5- (2-oxopropylideneamino)-6-d-ribitylaminouracil" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 459 no PDB 4NQD . "Crystal Structure Of Tcr-mr1 Ternary Complex And Non-covalently Bound 5-(2-oxopropylideneamino)-6-d-ribitylaminouracil" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 460 no PDB 4NQE . "Crystal Structure Of Tcr-mr1 Ternary Complex Bound To 5-(2- Oxoethylideneamino)-6-d-ribitylaminouracil" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 461 no PDB 4NQV . "Crystal Structure Of Hla A*0101 In Complex With Np44, An 9-mer Influenza Epitope" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 462 no PDB 4NQX . "Crystal Structure Of Hla A*0101 In Complex With Np44-s7n, An 9-mer Influenza Epitope" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 463 no PDB 4NT6 . "Hla-c*0801 Crystal Structure" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 464 no PDB 4O2C . "An Nt-acetylated Peptide Complexed With Hla-b*3901" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 465 no PDB 4O2E . "A Peptide Complexed With Hla-b*3901" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 466 no PDB 4O2F . "A Peptide Complexed With Hla-b*3901" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 467 no PDB 4PJ5 . "Structure Of Human Mr1-ac-6-fp In Complex With Human Mait Trbv6-1 Tcr" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 468 no PDB 4PJ7 . "Structure Of Human Mr1-5-op-ru In Complex With Human Mait Trbv6-4 Tcr" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 469 no PDB 4PJ8 . "Structure Of Human Mr1-5-op-ru In Complex With Human Mait Trbv20 Tcr" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 470 no PDB 4PJ9 . "Structure Of Human Mr1-5-op-ru In Complex With Human Mait Traj20 Tcr" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 471 no PDB 4PJA . "Structure Of Human Mr1-5-op-ru In Complex With Human Mait B-b10 Tcr" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 472 no PDB 4PJB . "Structure Of Human Mr1-5-op-ru In Complex With Human Mait B-f3-c1 Tcr" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 473 no PDB 4PJC . "Structure Of Human Mr1-5-op-ru In Complex With Human Mait C-a11 Tcr" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 474 no PDB 4PJD . "Structure Of Human Mr1-5-op-ru In Complex With Human Mait C-c10 Tcr" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 475 no PDB 4PJE . "Structure Of Human Mr1-ac-6-fp In Complex With Human Mait B-b10 Tcr" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 476 no PDB 4PJF . "Structure Of Human Mr1-ac-6-fp In Complex With Human Mait B-c10 Tcr" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 477 no PDB 4PJG . "Structure Of Human Mr1-ac-6-fp In Complex With Human Mait B-f3-c1 Tcr" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 478 no PDB 4PJH . "Structure Of Human Mr1-ac-6-fp In Complex With Human Mait B-g8 Tcr" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 479 no PDB 4PJI . "Structure Of Human Mr1-ac-6-fp In Complex With Human Mait C-c10 Tcr" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 480 no PDB 4PJX . "Structure Of Human Mr1-ac-6-fp In Complex With Human Mait C-a11 Tcr" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 481 no PDB 4PR5 . "Crystal Structure Of A Hla-b*35:01-hpvg-d5" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 482 no PDB 4PRA . "Crystal Structure Of A Hla-b*35:01-hpvg-q5" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 483 no PDB 4PRB . "Crystal Structure Of A Hla-b*35:08-hpvg-a4" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 484 no PDB 4PRD . "Crystal Structure Of A Hla-b*35:08-hpvg-d5" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 485 no PDB 4PRE . "Crystal Structure Of A Hla-b*35:08-hpvg-q5" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 486 no PDB 4PRH . "Crystal Structure Of Tk3 Tcr-hla-b*35:08-hpvg-d5 Complex" . . . . . 100.00 100 98.00 99.00 1.47e-66 . . . . 16587 1 487 no PDB 4PRI . "Crystal Structure Of Tk3 Tcr-hla-b*35:08-hpvg Complex" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 488 no PDB 4PRN . "Crystal Structure Of A Hla-b*35:01-hpvg-a4" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 489 no PDB 4PRP . "Crystal Structure Of Tk3 Tcr-hla-b*35:01-hpvg-q5 Complex" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 490 no PDB 4QOK . "Structural Basis For Ineffective T-cell Responses To Mhc Anchor Residue Improved Heteroclitic Peptides" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 491 no PDB 4QRP . "Crystal Structure Of Hla B*0801 In Complex With Hskkkcdel And Dd31 Tcr" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 492 no PDB 4QRQ . "Crystal Structure Of Hla B*0801 In Complex With Hskkkcdel" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 493 no PDB 4QRR . "Crystal Structure Of Hla B*3501-ips In Complex With A Delta-beta Tcr, Clone 12 Tcr" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 494 no PDB 4QRS . "Crystal Structure Of Hla B*0801 In Complex With Elk_iym, Elkrkmiym" . . . . . 100.00 100 98.00 98.00 1.04e-65 . . . . 16587 1 495 no PDB 4QRT . "Crystal Structure Of Hla B*0801 In Complex With Eln_yym, Elnrkmiym" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 496 no PDB 4QRU . "Crystal Structure Of Hla B*0801 In Complex With Elr_mym, Elrrkmmym" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 497 no PDB 4R9H . "Crystal Structure Of Dimeric S33c Beta-2 Microglobulin Mutant At 1.9 Angstrom Resolution" . . . . . 100.00 100 98.00 98.00 4.20e-66 . . . . 16587 1 498 no PDB 4RA3 . "Crystal Structure Of Dimeric S33c Beta-2 Microglobulin Mutant In Complex With Thioflavin (tht) At 2.8 Angstrom Resolution" . . . . . 100.00 100 98.00 98.00 4.20e-66 . . . . 16587 1 499 no PDB 4RAH . "Crystal Structure Of Dimeric S33c Beta-2 Microglobulin Mutant At 1.4 Angstrom Resolution" . . . . . 100.00 100 98.00 98.00 4.20e-66 . . . . 16587 1 500 no PDB 4U1H . "Hla Class I Micropolymorphisms Determine Peptide-hla Landscape And Dictate Differential Hiv-1 Escape Through Identical Epitopes" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 501 no PDB 4U1I . "Hla Class I Micropolymorphisms Determine Peptide-hla Landscape And Dictate Differential Hiv-1 Escape Through Identical Epitopes" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 502 no PDB 4U1J . "Hla Class I Micropolymorphisms Determine Peptide-hla Landscape And Dictate Differential Hiv-1 Escape Through Identical Epitopes" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 503 no PDB 4U1K . "Hla Class I Micropolymorphisms Determine Peptide-hla Landscape And Dictate Differential Hiv-1 Escape Through Identical Epitopes" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 504 no PDB 4U1L . "Hla Class I Micropolymorphisms Determine Peptide-hla Landscape And Dictate Differential Hiv-1 Escape Through Identical Epitopes" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 505 no PDB 4U1M . "Hla Class I Micropolymorphisms Determine Peptide-hla Landscape And Dictate Differential Hiv-1 Escape Through Identical Epitopes" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 506 no PDB 4U1N . "Hla Class I Micropolymorphisms Determine Peptide-hla Landscape And Dictate Differential Hiv-1 Escape Through Identical Epitopes" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 507 no PDB 4U1S . "Hla Class I Micropolymorphisms Determine Peptide-hla Landscape And Dictate Differential Hiv-1 Escape Through Identical Epitopes" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 508 no PDB 4U6X . "Crystal Structure Of Hla-a*0201 In Complex With Alqda, A 15 Mer Self- Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 509 no PDB 4U6Y . "Crystal Structure Of Hla-a*0201 In Complex With Flndk, A 15 Mer Self- Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 510 no PDB 4UQ2 . "Crystal Structure Of Hla-a1101 In Complex With An Azobenzene-containing Peptide" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 511 no PDB 4UQ3 . "Crystal Structure Of Hla-a0201 In Complex With An Azobenzene-containing Peptide" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 512 no PDB 4WDI . "Weak Tcr Binding To An Unstable Insulin Epitope Drives Type 1 Diabetes" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 513 no PDB 4WJ5 . "Structure Of Hla-a2 In Complex With An Altered Peptide Ligands Based On Mart-1 Variant Epitope" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 514 no PDB 4WO4 . "The Molecular Bases Of Delta/alpha Beta T Cell-mediated Antigen Recognition." . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 515 no PDB 4WU5 . "Hla-a24 In Complex With Hiv-1 Nef134-8(wt)" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 516 no PDB 4WU7 . "Hla-a24 In Complex With Hiv-1 Nef134-8(2f)" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 517 no PDB 4X6C . "Cd1a Ternary Complex With Lysophosphatidylcholine And Bk6 Tcr" . . . . . 99.00 105 98.99 98.99 8.92e-66 . . . . 16587 1 518 no PDB 4X6D . "Cd1a Ternary Complex With Endogenous Lipids And Bk6 Tcr" . . . . . 99.00 99 98.99 98.99 5.01e-66 . . . . 16587 1 519 no PDB 4X6E . "Cd1a Binary Complex With Lysophosphatidylcholine" . . . . . 99.00 105 98.99 98.99 8.92e-66 . . . . 16587 1 520 no PDB 4X6F . "Cd1a Binary Complex With Sphingomyelin" . . . . . 99.00 105 98.99 98.99 8.92e-66 . . . . 16587 1 521 no PDB 4XXC . "Hla-b*1801 In Complex With A Self-peptide, Deleikay" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 522 no PDB 4Z76 . "Weak Tcr Binding To An Unstable Insulin Epitope Drives Type 1 Diabetes" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 523 no PDB 4Z77 . "Weak Tcr Binding To An Unstable Insulin Epitope Drives Type 1 Diabetes" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 524 no PDB 4Z78 . "Weak Tcr Binding To An Unstable Insulin Epitope Drives Type 1 Diabetes" . . . . . 100.00 100 99.00 99.00 6.64e-67 . . . . 16587 1 525 no PDB 5BXF . "Apo Fcrn Structure At Ph 4.5" . . . . . 99.00 119 98.99 98.99 1.03e-66 . . . . 16587 1 526 no DBJ BAA35182 . "beta 2-microglobulin [Homo sapiens]" . . . . . 99.00 119 98.99 98.99 1.03e-66 . . . . 16587 1 527 no DBJ BAG38125 . "unnamed protein product [Homo sapiens]" . . . . . 99.00 119 98.99 98.99 1.03e-66 . . . . 16587 1 528 no DBJ BAG72952 . "beta-2-microglobulin [synthetic construct]" . . . . . 99.00 119 98.99 98.99 1.03e-66 . . . . 16587 1 529 no EMBL CAA23830 . "beta-2 microglobulin [Homo sapiens]" . . . . . 99.00 110 98.99 98.99 2.72e-66 . . . . 16587 1 530 no EMBL CAG33347 . "B2M [Homo sapiens]" . . . . . 99.00 119 97.98 98.99 5.51e-66 . . . . 16587 1 531 no EMBL CAH92078 . "hypothetical protein [Pongo abelii]" . . . . . 99.00 119 98.99 98.99 1.03e-66 . . . . 16587 1 532 no GB AAA51811 . "beta-2-microglobulin [Homo sapiens]" . . . . . 99.00 119 97.98 97.98 2.20e-65 . . . . 16587 1 533 no GB AAA87972 . "beta-2-microglobulin [Pan troglodytes]" . . . . . 99.00 119 98.99 98.99 1.03e-66 . . . . 16587 1 534 no GB AAA88008 . "beta-2-microglobulin [Gorilla gorilla]" . . . . . 99.00 119 98.99 98.99 1.03e-66 . . . . 16587 1 535 no GB AAB25312 . "beta 2-microglobulin [Homo sapiens]" . . . . . 75.00 101 98.67 98.67 1.44e-46 . . . . 16587 1 536 no GB AAB35347 . "pI 5.3 beta 2-microglobulin, BM [human, urine, chronic renal failure patient, Peptide, 98 aa]" . . . . . 98.00 98 98.98 98.98 3.46e-65 . . . . 16587 1 537 no REF NP_001009066 . "beta-2-microglobulin precursor [Pan troglodytes]" . . . . . 99.00 119 98.99 98.99 1.03e-66 . . . . 16587 1 538 no REF NP_001127503 . "beta-2-microglobulin precursor [Pongo abelii]" . . . . . 99.00 119 98.99 98.99 1.03e-66 . . . . 16587 1 539 no REF NP_004039 . "beta-2-microglobulin precursor [Homo sapiens]" . . . . . 99.00 119 98.99 98.99 1.03e-66 . . . . 16587 1 540 no REF XP_004056148 . "PREDICTED: beta-2-microglobulin isoform 1 [Gorilla gorilla gorilla]" . . . . . 99.00 119 98.99 98.99 1.03e-66 . . . . 16587 1 541 no REF XP_004056149 . "PREDICTED: beta-2-microglobulin isoform 2 [Gorilla gorilla gorilla]" . . . . . 99.00 119 98.99 98.99 1.03e-66 . . . . 16587 1 542 no SP P16213 . "RecName: Full=Beta-2-microglobulin; Flags: Precursor" . . . . . 99.00 119 98.99 98.99 1.03e-66 . . . . 16587 1 543 no SP P61769 . "RecName: Full=Beta-2-microglobulin; Contains: RecName: Full=Beta-2-microglobulin form pI 5.3; Flags: Precursor" . . . . . 99.00 119 98.99 98.99 1.03e-66 . . . . 16587 1 544 no SP P61770 . "RecName: Full=Beta-2-microglobulin; Flags: Precursor" . . . . . 99.00 119 98.99 98.99 1.03e-66 . . . . 16587 1 545 no SP P61771 . "RecName: Full=Beta-2-microglobulin; Flags: Precursor" . . . . . 99.00 119 98.99 98.99 1.03e-66 . . . . 16587 1 stop_ loop_ _Entity_comp_index.ID _Entity_comp_index.Auth_seq_ID _Entity_comp_index.Comp_ID _Entity_comp_index.Comp_label _Entity_comp_index.Entry_ID _Entity_comp_index.Entity_ID 1 0 MET . 16587 1 2 1 ILE . 16587 1 3 2 GLN . 16587 1 4 3 ARG . 16587 1 5 4 THR . 16587 1 6 5 PRO . 16587 1 7 6 LYS . 16587 1 8 7 ILE . 16587 1 9 8 GLN . 16587 1 10 9 VAL . 16587 1 11 10 TYR . 16587 1 12 11 SER . 16587 1 13 12 ARG . 16587 1 14 13 HIS . 16587 1 15 14 PRO . 16587 1 16 15 ALA . 16587 1 17 16 GLU . 16587 1 18 17 ASN . 16587 1 19 18 GLY . 16587 1 20 19 LYS . 16587 1 21 20 SER . 16587 1 22 21 ASN . 16587 1 23 22 PHE . 16587 1 24 23 LEU . 16587 1 25 24 ASN . 16587 1 26 25 CYS . 16587 1 27 26 TYR . 16587 1 28 27 VAL . 16587 1 29 28 SER . 16587 1 30 29 GLY . 16587 1 31 30 PHE . 16587 1 32 31 HIS . 16587 1 33 32 PRO . 16587 1 34 33 SER . 16587 1 35 34 ASP . 16587 1 36 35 ILE . 16587 1 37 36 GLU . 16587 1 38 37 VAL . 16587 1 39 38 ASP . 16587 1 40 39 LEU . 16587 1 41 40 LEU . 16587 1 42 41 LYS . 16587 1 43 42 ASN . 16587 1 44 43 GLY . 16587 1 45 44 GLU . 16587 1 46 45 ARG . 16587 1 47 46 ILE . 16587 1 48 47 GLU . 16587 1 49 48 LYS . 16587 1 50 49 VAL . 16587 1 51 50 GLU . 16587 1 52 51 HIS . 16587 1 53 52 SER . 16587 1 54 53 ASP . 16587 1 55 54 LEU . 16587 1 56 55 SER . 16587 1 57 56 PHE . 16587 1 58 57 SER . 16587 1 59 58 LYS . 16587 1 60 59 ASP . 16587 1 61 60 GLY . 16587 1 62 61 SER . 16587 1 63 62 PHE . 16587 1 64 63 TYR . 16587 1 65 64 LEU . 16587 1 66 65 LEU . 16587 1 67 66 TYR . 16587 1 68 67 TYR . 16587 1 69 68 THR . 16587 1 70 69 GLU . 16587 1 71 70 PHE . 16587 1 72 71 THR . 16587 1 73 72 PRO . 16587 1 74 73 THR . 16587 1 75 74 GLU . 16587 1 76 75 LYS . 16587 1 77 76 ASP . 16587 1 78 77 GLU . 16587 1 79 78 TYR . 16587 1 80 79 ALA . 16587 1 81 80 CYS . 16587 1 82 81 ARG . 16587 1 83 82 VAL . 16587 1 84 83 ASN . 16587 1 85 84 HIS . 16587 1 86 85 VAL . 16587 1 87 86 THR . 16587 1 88 87 LEU . 16587 1 89 88 SER . 16587 1 90 89 GLN . 16587 1 91 90 PRO . 16587 1 92 91 LYS . 16587 1 93 92 ILE . 16587 1 94 93 VAL . 16587 1 95 94 LYS . 16587 1 96 95 TRP . 16587 1 97 96 ASP . 16587 1 98 97 ARG . 16587 1 99 98 ASP . 16587 1 100 99 MET . 16587 1 stop_ loop_ _Entity_poly_seq.Hetero _Entity_poly_seq.Mon_ID _Entity_poly_seq.Num _Entity_poly_seq.Comp_index_ID _Entity_poly_seq.Entry_ID _Entity_poly_seq.Entity_ID . MET 1 1 16587 1 . ILE 2 2 16587 1 . GLN 3 3 16587 1 . ARG 4 4 16587 1 . THR 5 5 16587 1 . PRO 6 6 16587 1 . LYS 7 7 16587 1 . ILE 8 8 16587 1 . GLN 9 9 16587 1 . VAL 10 10 16587 1 . TYR 11 11 16587 1 . SER 12 12 16587 1 . ARG 13 13 16587 1 . HIS 14 14 16587 1 . PRO 15 15 16587 1 . ALA 16 16 16587 1 . GLU 17 17 16587 1 . ASN 18 18 16587 1 . GLY 19 19 16587 1 . LYS 20 20 16587 1 . SER 21 21 16587 1 . ASN 22 22 16587 1 . PHE 23 23 16587 1 . LEU 24 24 16587 1 . ASN 25 25 16587 1 . CYS 26 26 16587 1 . TYR 27 27 16587 1 . VAL 28 28 16587 1 . SER 29 29 16587 1 . GLY 30 30 16587 1 . PHE 31 31 16587 1 . HIS 32 32 16587 1 . PRO 33 33 16587 1 . SER 34 34 16587 1 . ASP 35 35 16587 1 . ILE 36 36 16587 1 . GLU 37 37 16587 1 . VAL 38 38 16587 1 . ASP 39 39 16587 1 . LEU 40 40 16587 1 . LEU 41 41 16587 1 . LYS 42 42 16587 1 . ASN 43 43 16587 1 . GLY 44 44 16587 1 . GLU 45 45 16587 1 . ARG 46 46 16587 1 . ILE 47 47 16587 1 . GLU 48 48 16587 1 . LYS 49 49 16587 1 . VAL 50 50 16587 1 . GLU 51 51 16587 1 . HIS 52 52 16587 1 . SER 53 53 16587 1 . ASP 54 54 16587 1 . LEU 55 55 16587 1 . SER 56 56 16587 1 . PHE 57 57 16587 1 . SER 58 58 16587 1 . LYS 59 59 16587 1 . ASP 60 60 16587 1 . GLY 61 61 16587 1 . SER 62 62 16587 1 . PHE 63 63 16587 1 . TYR 64 64 16587 1 . LEU 65 65 16587 1 . LEU 66 66 16587 1 . TYR 67 67 16587 1 . TYR 68 68 16587 1 . THR 69 69 16587 1 . GLU 70 70 16587 1 . PHE 71 71 16587 1 . THR 72 72 16587 1 . PRO 73 73 16587 1 . THR 74 74 16587 1 . GLU 75 75 16587 1 . LYS 76 76 16587 1 . ASP 77 77 16587 1 . GLU 78 78 16587 1 . TYR 79 79 16587 1 . ALA 80 80 16587 1 . CYS 81 81 16587 1 . ARG 82 82 16587 1 . VAL 83 83 16587 1 . ASN 84 84 16587 1 . HIS 85 85 16587 1 . VAL 86 86 16587 1 . THR 87 87 16587 1 . LEU 88 88 16587 1 . SER 89 89 16587 1 . GLN 90 90 16587 1 . PRO 91 91 16587 1 . LYS 92 92 16587 1 . ILE 93 93 16587 1 . VAL 94 94 16587 1 . LYS 95 95 16587 1 . TRP 96 96 16587 1 . ASP 97 97 16587 1 . ARG 98 98 16587 1 . ASP 99 99 16587 1 . MET 100 100 16587 1 stop_ save_ #################### # Natural source # #################### save_natural_source _Entity_natural_src_list.Sf_category natural_source _Entity_natural_src_list.Sf_framecode natural_source _Entity_natural_src_list.Entry_ID 16587 _Entity_natural_src_list.ID 1 loop_ _Entity_natural_src.ID _Entity_natural_src.Entity_ID _Entity_natural_src.Entity_label _Entity_natural_src.Entity_chimera_segment_ID _Entity_natural_src.NCBI_taxonomy_ID _Entity_natural_src.Type _Entity_natural_src.Common _Entity_natural_src.Organism_name_scientific _Entity_natural_src.Organism_name_common _Entity_natural_src.Organism_acronym _Entity_natural_src.ICTVdb_decimal_code _Entity_natural_src.Superkingdom _Entity_natural_src.Kingdom _Entity_natural_src.Genus _Entity_natural_src.Species _Entity_natural_src.Strain _Entity_natural_src.Variant _Entity_natural_src.Subvariant _Entity_natural_src.Organ _Entity_natural_src.Tissue _Entity_natural_src.Tissue_fraction _Entity_natural_src.Cell_line _Entity_natural_src.Cell_type _Entity_natural_src.ATCC_number _Entity_natural_src.Organelle _Entity_natural_src.Cellular_location _Entity_natural_src.Fragment _Entity_natural_src.Fraction _Entity_natural_src.Secretion _Entity_natural_src.Plasmid _Entity_natural_src.Plasmid_details _Entity_natural_src.Gene_mnemonic _Entity_natural_src.Dev_stage _Entity_natural_src.Details _Entity_natural_src.Citation_ID _Entity_natural_src.Citation_label _Entity_natural_src.Entry_ID _Entity_natural_src.Entity_natural_src_list_ID 1 1 $entity . 9606 organism . 'Homo sapiens' Human . . Eukaryota Metazoa Homo sapiens . . . . . . . . . . . . . . . . . . . . . 16587 1 stop_ save_ ######################### # Experimental source # ######################### save_experimental_source _Entity_experimental_src_list.Sf_category experimental_source _Entity_experimental_src_list.Sf_framecode experimental_source _Entity_experimental_src_list.Entry_ID 16587 _Entity_experimental_src_list.ID 1 loop_ _Entity_experimental_src.ID _Entity_experimental_src.Entity_ID _Entity_experimental_src.Entity_label _Entity_experimental_src.Entity_chimera_segment_ID _Entity_experimental_src.Production_method _Entity_experimental_src.Host_org_scientific_name _Entity_experimental_src.Host_org_name_common _Entity_experimental_src.Host_org_details _Entity_experimental_src.Host_org_NCBI_taxonomy_ID _Entity_experimental_src.Host_org_genus _Entity_experimental_src.Host_org_species _Entity_experimental_src.Host_org_strain _Entity_experimental_src.Host_org_variant _Entity_experimental_src.Host_org_subvariant _Entity_experimental_src.Host_org_organ _Entity_experimental_src.Host_org_tissue _Entity_experimental_src.Host_org_tissue_fraction _Entity_experimental_src.Host_org_cell_line _Entity_experimental_src.Host_org_cell_type _Entity_experimental_src.Host_org_cellular_location _Entity_experimental_src.Host_org_organelle _Entity_experimental_src.Host_org_gene _Entity_experimental_src.Host_org_culture_collection _Entity_experimental_src.Host_org_ATCC_number _Entity_experimental_src.Vector_type _Entity_experimental_src.PDBview_host_org_vector_name _Entity_experimental_src.PDBview_plasmid_name _Entity_experimental_src.Vector_name _Entity_experimental_src.Vector_details _Entity_experimental_src.Vendor_name _Entity_experimental_src.Host_org_dev_stage _Entity_experimental_src.Details _Entity_experimental_src.Citation_ID _Entity_experimental_src.Citation_label _Entity_experimental_src.Entry_ID _Entity_experimental_src.Entity_experimental_src_list_ID 1 1 $entity . 'recombinant technology' 'Escherichia coli' . . . Escherichia coli . . . . . . . . . . . . . . . . BL21DE3 . . . . . . 16587 1 stop_ save_ ##################################### # Sample contents and methodology # ##################################### ######################## # Sample description # ######################## save_sample_1 _Sample.Sf_category sample _Sample.Sf_framecode sample_1 _Sample.Entry_ID 16587 _Sample.ID 1 _Sample.Type solution _Sample.Sub_type . _Sample.Details . _Sample.Aggregate_sample_number 2 _Sample.Solvent_system trifluoroethanol/water _Sample.Preparation_date . _Sample.Preparation_expiration_date . _Sample.Polycrystallization_protocol . _Sample.Single_crystal_protocol . _Sample.Crystal_grow_apparatus . _Sample.Crystal_grow_atmosphere . _Sample.Crystal_grow_details . _Sample.Crystal_grow_method . _Sample.Crystal_grow_method_cit_ID . _Sample.Crystal_grow_pH . _Sample.Crystal_grow_pH_range . _Sample.Crystal_grow_pressure . _Sample.Crystal_grow_pressure_esd . _Sample.Crystal_grow_seeding . _Sample.Crystal_grow_seeding_cit_ID . _Sample.Crystal_grow_temp . _Sample.Crystal_grow_temp_details . _Sample.Crystal_grow_temp_esd . _Sample.Crystal_grow_time . _Sample.Oriented_sample_prep_protocol . _Sample.Lyophilization_cryo_protectant . _Sample.Storage_protocol . loop_ _Sample_component.ID _Sample_component.Mol_common_name _Sample_component.Isotopic_labeling _Sample_component.Assembly_ID _Sample_component.Assembly_label _Sample_component.Entity_ID _Sample_component.Entity_label _Sample_component.Product_ID _Sample_component.Type _Sample_component.Concentration_val _Sample_component.Concentration_val_min _Sample_component.Concentration_val_max _Sample_component.Concentration_val_units _Sample_component.Concentration_val_err _Sample_component.Vendor _Sample_component.Vendor_product_name _Sample_component.Vendor_product_code _Sample_component.Entry_ID _Sample_component.Sample_ID 1 'W60G beta2-microglobulin' '[U-100% 15N]' . . 1 $entity . . 0.6 . . mM . . . . 16587 1 2 H2O '[U-100% 2H]' . . . . . . 0.08 . . v/v . . . . 16587 1 3 H2O 'natural abundance' . . . . . . 0.74 . . v/v . . . . 16587 1 4 TFE '[U-99% 2H]' . . . . . . 0.18 . . v/v . . . . 16587 1 5 'sodium chloride' 'natural abundance' . . . . . . 100 . . mM . . . . 16587 1 6 'sodium phosphate' 'natural abundance' . . . . . . 70 . . mM . . . . 16587 1 stop_ save_ ####################### # Sample conditions # ####################### save_sample_conditions_1 _Sample_condition_list.Sf_category sample_conditions _Sample_condition_list.Sf_framecode sample_conditions_1 _Sample_condition_list.Entry_ID 16587 _Sample_condition_list.ID 1 _Sample_condition_list.Details . loop_ _Sample_condition_variable.Type _Sample_condition_variable.Val _Sample_condition_variable.Val_err _Sample_condition_variable.Val_units _Sample_condition_variable.Entry_ID _Sample_condition_variable.Sample_condition_list_ID pH 6.6 . pH 16587 1 pressure 1 . atm 16587 1 temperature 306 . K 16587 1 stop_ save_ ############################ # Computer software used # ############################ save_CARA _Software.Sf_category software _Software.Sf_framecode CARA _Software.Entry_ID 16587 _Software.ID 1 _Software.Name CARA _Software.Version 1.8.4 _Software.Details . loop_ _Vendor.Name _Vendor.Address _Vendor.Electronic_address _Vendor.Entry_ID _Vendor.Software_ID 'Keller and Wuthrich' . . 16587 1 stop_ loop_ _Task.Task _Task.Entry_ID _Task.Software_ID 'chemical shift assignment' 16587 1 stop_ save_ save_TOPSPIN _Software.Sf_category software _Software.Sf_framecode TOPSPIN _Software.Entry_ID 16587 _Software.ID 2 _Software.Name TOPSPIN _Software.Version . _Software.Details . loop_ _Vendor.Name _Vendor.Address _Vendor.Electronic_address _Vendor.Entry_ID _Vendor.Software_ID 'Bruker Biospin' . . 16587 2 stop_ loop_ _Task.Task _Task.Entry_ID _Task.Software_ID collection 16587 2 processing 16587 2 stop_ save_ save_Felix _Software.Sf_category software _Software.Sf_framecode Felix _Software.Entry_ID 16587 _Software.ID 3 _Software.Name FELIX _Software.Version . _Software.Details . loop_ _Vendor.Name _Vendor.Address _Vendor.Electronic_address _Vendor.Entry_ID _Vendor.Software_ID 'Accelrys Software Inc.' . . 16587 3 stop_ loop_ _Task.Task _Task.Entry_ID _Task.Software_ID 'chemical shift assignment' 16587 3 stop_ save_ ######################### # Experimental detail # ######################### ################################## # NMR Spectrometer definitions # ################################## save_spectrometer_1 _NMR_spectrometer.Sf_category NMR_spectrometer _NMR_spectrometer.Sf_framecode spectrometer_1 _NMR_spectrometer.Entry_ID 16587 _NMR_spectrometer.ID 1 _NMR_spectrometer.Details . _NMR_spectrometer.Manufacturer Bruker _NMR_spectrometer.Model Avance _NMR_spectrometer.Serial_number . _NMR_spectrometer.Field_strength 500 save_ save_NMR_spectrometer_list _NMR_spectrometer_list.Sf_category NMR_spectrometer_list _NMR_spectrometer_list.Sf_framecode NMR_spectrometer_list _NMR_spectrometer_list.Entry_ID 16587 _NMR_spectrometer_list.ID 1 loop_ _NMR_spectrometer_view.ID _NMR_spectrometer_view.Name _NMR_spectrometer_view.Manufacturer _NMR_spectrometer_view.Model _NMR_spectrometer_view.Serial_number _NMR_spectrometer_view.Field_strength _NMR_spectrometer_view.Details _NMR_spectrometer_view.Citation_ID _NMR_spectrometer_view.Citation_label _NMR_spectrometer_view.Entry_ID _NMR_spectrometer_view.NMR_spectrometer_list_ID 1 spectrometer_1 Bruker Avance . 500 . . . 16587 1 stop_ save_ ############################# # NMR applied experiments # ############################# save_experiment_list _Experiment_list.Sf_category experiment_list _Experiment_list.Sf_framecode experiment_list _Experiment_list.Entry_ID 16587 _Experiment_list.ID 1 _Experiment_list.Details . loop_ _Experiment.ID _Experiment.Name _Experiment.Raw_data_flag _Experiment.NMR_spec_expt_ID _Experiment.NMR_spec_expt_label _Experiment.MS_expt_ID _Experiment.MS_expt_label _Experiment.SAXS_expt_ID _Experiment.SAXS_expt_label _Experiment.FRET_expt_ID _Experiment.FRET_expt_label _Experiment.EMR_expt_ID _Experiment.EMR_expt_label _Experiment.Sample_ID _Experiment.Sample_label _Experiment.Sample_state _Experiment.Sample_volume _Experiment.Sample_volume_units _Experiment.Sample_condition_list_ID _Experiment.Sample_condition_list_label _Experiment.Sample_spinning_rate _Experiment.Sample_angle _Experiment.NMR_tube_type _Experiment.NMR_spectrometer_ID _Experiment.NMR_spectrometer_label _Experiment.NMR_spectrometer_probe_ID _Experiment.NMR_spectrometer_probe_label _Experiment.NMR_spectral_processing_ID _Experiment.NMR_spectral_processing_label _Experiment.Mass_spectrometer_ID _Experiment.Mass_spectrometer_label _Experiment.Xray_instrument_ID _Experiment.Xray_instrument_label _Experiment.Fluorescence_instrument_ID _Experiment.Fluorescence_instrument_label _Experiment.EMR_instrument_ID _Experiment.EMR_instrument_label _Experiment.Chromatographic_system_ID _Experiment.Chromatographic_system_label _Experiment.Chromatographic_column_ID _Experiment.Chromatographic_column_label _Experiment.Entry_ID _Experiment.Experiment_list_ID 1 '2D 1H-1H TOCSY' no . . . . . . . . . . 1 $sample_1 isotropic . . 1 $sample_conditions_1 . . . 1 $spectrometer_1 . . . . . . . . . . . . . . . . 16587 1 2 '3D 1H-15N NOESY' no . . . . . . . . . . 1 $sample_1 isotropic . . 1 $sample_conditions_1 . . . 1 $spectrometer_1 . . . . . . . . . . . . . . . . 16587 1 3 '3D 1H-15N TOCSY' no . . . . . . . . . . 1 $sample_1 isotropic . . 1 $sample_conditions_1 . . . 1 $spectrometer_1 . . . . . . . . . . . . . . . . 16587 1 4 '2D 1H-15N HSQC' no . . . . . . . . . . 1 $sample_1 isotropic . . 1 $sample_conditions_1 . . . 1 $spectrometer_1 . . . . . . . . . . . . . . . . 16587 1 stop_ save_ save_2D_1H-1H_TOCSY _NMR_spec_expt.Sf_category NMR_spectrometer_expt _NMR_spec_expt.Sf_framecode 2D_1H-1H_TOCSY _NMR_spec_expt.Entry_ID 16587 _NMR_spec_expt.ID 1 _NMR_spec_expt.Name '2D 1H-1H TOCSY' _NMR_spec_expt.Type . _NMR_spec_expt.Sample_volume . _NMR_spec_expt.Sample_volume_units . _NMR_spec_expt.NMR_tube_type . _NMR_spec_expt.Sample_spinning_rate . _NMR_spec_expt.Sample_angle . _NMR_spec_expt.NMR_spectrometer_ID 1 _NMR_spec_expt.NMR_spectrometer_label $spectrometer_1 _NMR_spec_expt.NMR_spectrometer_probe_ID . _NMR_spec_expt.NMR_spectrometer_probe_label . _NMR_spec_expt.Carrier_freq_switch_time . _NMR_spec_expt.Software_ID . _NMR_spec_expt.Software_label . _NMR_spec_expt.Method_ID . _NMR_spec_expt.Method_label . _NMR_spec_expt.Pulse_seq_accession_BMRB_code . _NMR_spec_expt.Details 'two different spectra acquired, with mixing times of 40 ms and 80 ms' save_ save_3D_1H-15N_NOESY _NMR_spec_expt.Sf_category NMR_spectrometer_expt _NMR_spec_expt.Sf_framecode 3D_1H-15N_NOESY _NMR_spec_expt.Entry_ID 16587 _NMR_spec_expt.ID 2 _NMR_spec_expt.Name '3D 1H-15N NOESY' _NMR_spec_expt.Type . _NMR_spec_expt.Sample_volume . _NMR_spec_expt.Sample_volume_units . _NMR_spec_expt.NMR_tube_type . _NMR_spec_expt.Sample_spinning_rate . _NMR_spec_expt.Sample_angle . _NMR_spec_expt.NMR_spectrometer_ID 1 _NMR_spec_expt.NMR_spectrometer_label $spectrometer_1 _NMR_spec_expt.NMR_spectrometer_probe_ID . _NMR_spec_expt.NMR_spectrometer_probe_label . _NMR_spec_expt.Carrier_freq_switch_time . _NMR_spec_expt.Software_ID . _NMR_spec_expt.Software_label . _NMR_spec_expt.Method_ID . _NMR_spec_expt.Method_label . _NMR_spec_expt.Pulse_seq_accession_BMRB_code . _NMR_spec_expt.Details 'mixing time 200 ms' save_ save_3D_1H-15N_TOCSY _NMR_spec_expt.Sf_category NMR_spectrometer_expt _NMR_spec_expt.Sf_framecode 3D_1H-15N_TOCSY _NMR_spec_expt.Entry_ID 16587 _NMR_spec_expt.ID 3 _NMR_spec_expt.Name '3D 1H-15N TOCSY' _NMR_spec_expt.Type . _NMR_spec_expt.Sample_volume . _NMR_spec_expt.Sample_volume_units . _NMR_spec_expt.NMR_tube_type . _NMR_spec_expt.Sample_spinning_rate . _NMR_spec_expt.Sample_angle . _NMR_spec_expt.NMR_spectrometer_ID 1 _NMR_spec_expt.NMR_spectrometer_label $spectrometer_1 _NMR_spec_expt.NMR_spectrometer_probe_ID . _NMR_spec_expt.NMR_spectrometer_probe_label . _NMR_spec_expt.Carrier_freq_switch_time . _NMR_spec_expt.Software_ID . _NMR_spec_expt.Software_label . _NMR_spec_expt.Method_ID . _NMR_spec_expt.Method_label . _NMR_spec_expt.Pulse_seq_accession_BMRB_code . _NMR_spec_expt.Details 'mixing time 65 ms' save_ #################### # NMR parameters # #################### ############################## # Assigned chemical shifts # ############################## ################################ # Chemical shift referencing # ################################ save_chemical_shift_reference_1 _Chem_shift_reference.Sf_category chem_shift_reference _Chem_shift_reference.Sf_framecode chemical_shift_reference_1 _Chem_shift_reference.Entry_ID 16587 _Chem_shift_reference.ID 1 _Chem_shift_reference.Details . loop_ _Chem_shift_ref.Atom_type _Chem_shift_ref.Atom_isotope_number _Chem_shift_ref.Mol_common_name _Chem_shift_ref.Atom_group _Chem_shift_ref.Concentration_val _Chem_shift_ref.Concentration_units _Chem_shift_ref.Solvent _Chem_shift_ref.Rank _Chem_shift_ref.Chem_shift_units _Chem_shift_ref.Chem_shift_val _Chem_shift_ref.Ref_method _Chem_shift_ref.Ref_type _Chem_shift_ref.Indirect_shift_ratio _Chem_shift_ref.External_ref_loc _Chem_shift_ref.External_ref_sample_geometry _Chem_shift_ref.External_ref_axis _Chem_shift_ref.Indirect_shift_ratio_cit_ID _Chem_shift_ref.Indirect_shift_ratio_cit_label _Chem_shift_ref.Ref_correction_type _Chem_shift_ref.Correction_val _Chem_shift_ref.Correction_val_cit_ID _Chem_shift_ref.Correction_val_cit_label _Chem_shift_ref.Entry_ID _Chem_shift_ref.Chem_shift_reference_ID H 1 DSS 'methyl protons' . . . . ppm 0.00 internal direct 1.000000000 . . . . . . . . . 16587 1 N 15 DSS 'methyl protons' . . . . ppm 0.00 na indirect 0.101329118 . . . . . . . . . 16587 1 stop_ save_ ################################### # Assigned chemical shift lists # ################################### ################################################################### # Chemical Shift Ambiguity Index Value Definitions # # # # The values other than 1 are used for those atoms with different # # chemical shifts that cannot be assigned to stereospecific atoms # # or to specific residues or chains. # # # # Index Value Definition # # # # 1 Unique (including isolated methyl protons, # # geminal atoms, and geminal methyl # # groups with identical chemical shifts) # # (e.g. ILE HD11, HD12, HD13 protons) # # 2 Ambiguity of geminal atoms or geminal methyl # # proton groups (e.g. ASP HB2 and HB3 # # protons, LEU CD1 and CD2 carbons, or # # LEU HD11, HD12, HD13 and HD21, HD22, # # HD23 methyl protons) # # 3 Aromatic atoms on opposite sides of # # symmetrical rings (e.g. TYR HE1 and HE2 # # protons) # # 4 Intraresidue ambiguities (e.g. LYS HG and # # HD protons or TRP HZ2 and HZ3 protons) # # 5 Interresidue ambiguities (LYS 12 vs. LYS 27) # # 6 Intermolecular ambiguities (e.g. ASP 31 CA # # in monomer 1 and ASP 31 CA in monomer 2 # # of an asymmetrical homodimer, duplex # # DNA assignments, or other assignments # # that may apply to atoms in one or more # # molecule in the molecular assembly) # # 9 Ambiguous, specific ambiguity not defined # # # ################################################################### save_assigned_chem_shift_list_1 _Assigned_chem_shift_list.Sf_category assigned_chemical_shifts _Assigned_chem_shift_list.Sf_framecode assigned_chem_shift_list_1 _Assigned_chem_shift_list.Entry_ID 16587 _Assigned_chem_shift_list.ID 1 _Assigned_chem_shift_list.Sample_condition_list_ID 1 _Assigned_chem_shift_list.Sample_condition_list_label $sample_conditions_1 _Assigned_chem_shift_list.Chem_shift_reference_ID 1 _Assigned_chem_shift_list.Chem_shift_reference_label $chemical_shift_reference_1 _Assigned_chem_shift_list.Chem_shift_1H_err . _Assigned_chem_shift_list.Chem_shift_13C_err . _Assigned_chem_shift_list.Chem_shift_15N_err . _Assigned_chem_shift_list.Chem_shift_31P_err . _Assigned_chem_shift_list.Chem_shift_2H_err . _Assigned_chem_shift_list.Chem_shift_19F_err . _Assigned_chem_shift_list.Error_derivation_method . _Assigned_chem_shift_list.Details . _Assigned_chem_shift_list.Text_data_format . _Assigned_chem_shift_list.Text_data . loop_ _Chem_shift_experiment.Experiment_ID _Chem_shift_experiment.Experiment_name _Chem_shift_experiment.Sample_ID _Chem_shift_experiment.Sample_label _Chem_shift_experiment.Sample_state _Chem_shift_experiment.Entry_ID _Chem_shift_experiment.Assigned_chem_shift_list_ID 1 '2D 1H-1H TOCSY' . . . 16587 1 2 '3D 1H-15N NOESY' . . . 16587 1 3 '3D 1H-15N TOCSY' . . . 16587 1 4 '2D 1H-15N HSQC' . . . 16587 1 stop_ loop_ _Chem_shift_software.Software_ID _Chem_shift_software.Software_label _Chem_shift_software.Method_ID _Chem_shift_software.Method_label _Chem_shift_software.Entry_ID _Chem_shift_software.Assigned_chem_shift_list_ID 1 $CARA . . 16587 1 3 $Felix . . 16587 1 stop_ loop_ _Atom_chem_shift.ID _Atom_chem_shift.Assembly_atom_ID _Atom_chem_shift.Entity_assembly_ID _Atom_chem_shift.Entity_ID _Atom_chem_shift.Comp_index_ID _Atom_chem_shift.Seq_ID _Atom_chem_shift.Comp_ID _Atom_chem_shift.Atom_ID _Atom_chem_shift.Atom_type _Atom_chem_shift.Atom_isotope_number _Atom_chem_shift.Val _Atom_chem_shift.Val_err _Atom_chem_shift.Assign_fig_of_merit _Atom_chem_shift.Ambiguity_code _Atom_chem_shift.Occupancy _Atom_chem_shift.Resonance_ID _Atom_chem_shift.Auth_entity_assembly_ID _Atom_chem_shift.Auth_asym_ID _Atom_chem_shift.Auth_seq_ID _Atom_chem_shift.Auth_comp_ID _Atom_chem_shift.Auth_atom_ID _Atom_chem_shift.Details _Atom_chem_shift.Entry_ID _Atom_chem_shift.Assigned_chem_shift_list_ID 1 . 1 1 1 1 MET HA H 1 4.01 0.02 . 1 . . . . 0 MET HA . 16587 1 2 . 1 1 1 1 MET HB2 H 1 2.11 0.02 . 1 . . . . 0 MET HB2 . 16587 1 3 . 1 1 1 1 MET HB3 H 1 2.11 0.02 . 1 . . . . 0 MET HB3 . 16587 1 4 . 1 1 1 1 MET HG2 H 1 2.6 0.02 . 1 . . . . 0 MET HG2 . 16587 1 5 . 1 1 1 1 MET HG3 H 1 2.6 0.02 . 1 . . . . 0 MET HG3 . 16587 1 6 . 1 1 2 2 ILE HA H 1 4.24 0.02 . 1 . . . . 1 ILE HA . 16587 1 7 . 1 1 2 2 ILE HB H 1 1.88 0.02 . 1 . . . . 1 ILE HB . 16587 1 8 . 1 1 2 2 ILE HD11 H 1 0.78 0.02 . 1 . . . . 1 ILE HD1 . 16587 1 9 . 1 1 2 2 ILE HD12 H 1 0.78 0.02 . 1 . . . . 1 ILE HD1 . 16587 1 10 . 1 1 2 2 ILE HD13 H 1 0.78 0.02 . 1 . . . . 1 ILE HD1 . 16587 1 11 . 1 1 2 2 ILE HG12 H 1 1.54 0.02 . 2 . . . . 1 ILE HG12 . 16587 1 12 . 1 1 2 2 ILE HG13 H 1 1.23 0.02 . 2 . . . . 1 ILE HG13 . 16587 1 13 . 1 1 2 2 ILE HG21 H 1 0.93 0.02 . 1 . . . . 1 ILE HG2 . 16587 1 14 . 1 1 2 2 ILE HG22 H 1 0.93 0.02 . 1 . . . . 1 ILE HG2 . 16587 1 15 . 1 1 2 2 ILE HG23 H 1 0.93 0.02 . 1 . . . . 1 ILE HG2 . 16587 1 16 . 1 1 5 5 THR H H 1 8.03 0.02 . 1 . . . . 4 THR HN . 16587 1 17 . 1 1 5 5 THR HA H 1 4.59 0.02 . 1 . . . . 4 THR HA . 16587 1 18 . 1 1 5 5 THR HB H 1 4.12 0.02 . 1 . . . . 4 THR HB . 16587 1 19 . 1 1 5 5 THR HG21 H 1 1.3 0.02 . 1 . . . . 4 THR HG2 . 16587 1 20 . 1 1 5 5 THR HG22 H 1 1.3 0.02 . 1 . . . . 4 THR HG2 . 16587 1 21 . 1 1 5 5 THR HG23 H 1 1.3 0.02 . 1 . . . . 4 THR HG2 . 16587 1 22 . 1 1 5 5 THR N N 15 116.32 0.2 . 1 . . . . 4 THR N . 16587 1 23 . 1 1 6 6 PRO HA H 1 4.49 0.02 . 1 . . . . 5 PRO HA . 16587 1 24 . 1 1 6 6 PRO HB2 H 1 1.49 0.02 . 2 . . . . 5 PRO HB2 . 16587 1 25 . 1 1 6 6 PRO HG2 H 1 1.68 0.02 . 2 . . . . 5 PRO HG2 . 16587 1 26 . 1 1 7 7 LYS H H 1 8.43 0.02 . 1 . . . . 6 LYS HN . 16587 1 27 . 1 1 7 7 LYS HA H 1 4.64 0.02 . 1 . . . . 6 LYS HA . 16587 1 28 . 1 1 7 7 LYS N N 15 120.8 0.2 . 1 . . . . 6 LYS N . 16587 1 29 . 1 1 8 8 ILE H H 1 7.85 0.02 . 1 . . . . 7 ILE HN . 16587 1 30 . 1 1 8 8 ILE HA H 1 5.43 0.02 . 1 . . . . 7 ILE HA . 16587 1 31 . 1 1 8 8 ILE HB H 1 1.73 0.02 . 1 . . . . 7 ILE HB . 16587 1 32 . 1 1 8 8 ILE N N 15 121.67 0.2 . 1 . . . . 7 ILE N . 16587 1 33 . 1 1 9 9 GLN H H 1 9.39 0.02 . 1 . . . . 8 GLN HN . 16587 1 34 . 1 1 9 9 GLN HA H 1 5.01 0.02 . 1 . . . . 8 GLN HA . 16587 1 35 . 1 1 9 9 GLN N N 15 125.28 0.2 . 1 . . . . 8 GLN N . 16587 1 36 . 1 1 10 10 VAL H H 1 8.96 0.02 . 1 . . . . 9 VAL HN . 16587 1 37 . 1 1 10 10 VAL HA H 1 5.47 0.02 . 1 . . . . 9 VAL HA . 16587 1 38 . 1 1 10 10 VAL HB H 1 2.05 0.02 . 1 . . . . 9 VAL HB . 16587 1 39 . 1 1 10 10 VAL HG11 H 1 0.98 0.02 . 2 . . . . 9 VAL HG1 . 16587 1 40 . 1 1 10 10 VAL HG12 H 1 0.98 0.02 . 2 . . . . 9 VAL HG1 . 16587 1 41 . 1 1 10 10 VAL HG13 H 1 0.98 0.02 . 2 . . . . 9 VAL HG1 . 16587 1 42 . 1 1 10 10 VAL N N 15 124.64 0.2 . 1 . . . . 9 VAL N . 16587 1 43 . 1 1 11 11 TYR H H 1 8.64 0.02 . 1 . . . . 10 TYR HN . 16587 1 44 . 1 1 11 11 TYR HA H 1 5.36 0.02 . 1 . . . . 10 TYR HA . 16587 1 45 . 1 1 11 11 TYR HB2 H 1 3.41 0.02 . 2 . . . . 10 TYR HB2 . 16587 1 46 . 1 1 11 11 TYR HB3 H 1 3.16 0.02 . 2 . . . . 10 TYR HB3 . 16587 1 47 . 1 1 11 11 TYR HD1 H 1 6.9 0.02 . 1 . . . . 10 TYR HD1 . 16587 1 48 . 1 1 11 11 TYR HD2 H 1 6.9 0.02 . 1 . . . . 10 TYR HD2 . 16587 1 49 . 1 1 11 11 TYR HE1 H 1 6.56 0.02 . 1 . . . . 10 TYR HE1 . 16587 1 50 . 1 1 11 11 TYR HE2 H 1 6.56 0.02 . 1 . . . . 10 TYR HE2 . 16587 1 51 . 1 1 11 11 TYR N N 15 122.75 0.2 . 1 . . . . 10 TYR N . 16587 1 52 . 1 1 12 12 SER H H 1 9.36 0.02 . 1 . . . . 11 SER HN . 16587 1 53 . 1 1 12 12 SER HA H 1 5.32 0.02 . 1 . . . . 11 SER HA . 16587 1 54 . 1 1 12 12 SER HB2 H 1 4.45 0.02 . 2 . . . . 11 SER HB2 . 16587 1 55 . 1 1 12 12 SER HB3 H 1 3.79 0.02 . 2 . . . . 11 SER HB3 . 16587 1 56 . 1 1 12 12 SER N N 15 116.78 0.2 . 1 . . . . 11 SER N . 16587 1 57 . 1 1 13 13 ARG H H 1 8.89 0.02 . 1 . . . . 12 ARG HN . 16587 1 58 . 1 1 13 13 ARG HA H 1 3.99 0.02 . 1 . . . . 12 ARG HA . 16587 1 59 . 1 1 13 13 ARG HB2 H 1 1.9 0.02 . 2 . . . . 12 ARG HB2 . 16587 1 60 . 1 1 13 13 ARG HG2 H 1 1.48 0.02 . 1 . . . . 12 ARG HG2 . 16587 1 61 . 1 1 13 13 ARG HG3 H 1 1.48 0.02 . 1 . . . . 12 ARG HG3 . 16587 1 62 . 1 1 13 13 ARG N N 15 122.64 0.2 . 1 . . . . 12 ARG N . 16587 1 63 . 1 1 14 14 HIS H H 1 8.36 0.02 . 1 . . . . 13 HIS HN . 16587 1 64 . 1 1 18 18 ASN HB2 H 1 2.75 0.02 . 2 . . . . 17 ASN HB2 . 16587 1 65 . 1 1 19 19 GLY H H 1 8.9 0.02 . 1 . . . . 18 GLY HN . 16587 1 66 . 1 1 19 19 GLY HA2 H 1 4.2 0.02 . 2 . . . . 18 GLY HA1 . 16587 1 67 . 1 1 19 19 GLY HA3 H 1 3.5 0.02 . 2 . . . . 18 GLY HA2 . 16587 1 68 . 1 1 19 19 GLY N N 15 109.68 0.2 . 1 . . . . 18 GLY N . 16587 1 69 . 1 1 20 20 LYS H H 1 7.87 0.02 . 1 . . . . 19 LYS HN . 16587 1 70 . 1 1 20 20 LYS HB2 H 1 1.86 0.02 . 2 . . . . 19 LYS HB2 . 16587 1 71 . 1 1 20 20 LYS HG2 H 1 1.35 0.02 . 2 . . . . 19 LYS HG2 . 16587 1 72 . 1 1 21 21 SER H H 1 8.32 0.02 . 1 . . . . 20 SER HN . 16587 1 73 . 1 1 21 21 SER HA H 1 4.32 0.02 . 1 . . . . 20 SER HA . 16587 1 74 . 1 1 21 21 SER HB2 H 1 3.77 0.02 . 1 . . . . 20 SER HB2 . 16587 1 75 . 1 1 21 21 SER HB3 H 1 3.77 0.02 . 1 . . . . 20 SER HB3 . 16587 1 76 . 1 1 21 21 SER N N 15 119.85 0.2 . 1 . . . . 20 SER N . 16587 1 77 . 1 1 22 22 ASN H H 1 8.92 0.02 . 1 . . . . 21 ASN HN . 16587 1 78 . 1 1 22 22 ASN HA H 1 4.88 0.02 . 1 . . . . 21 ASN HA . 16587 1 79 . 1 1 23 23 PHE H H 1 10.27 0.02 . 1 . . . . 22 PHE HN . 16587 1 80 . 1 1 23 23 PHE HA H 1 5.5 0.02 . 1 . . . . 22 PHE HA . 16587 1 81 . 1 1 23 23 PHE HB2 H 1 2.71 0.02 . 2 . . . . 22 PHE HB2 . 16587 1 82 . 1 1 23 23 PHE HD1 H 1 7.07 0.02 . 1 . . . . 22 PHE HD1 . 16587 1 83 . 1 1 23 23 PHE HD2 H 1 7.07 0.02 . 1 . . . . 22 PHE HD2 . 16587 1 84 . 1 1 23 23 PHE HE1 H 1 7.44 0.02 . 1 . . . . 22 PHE HE1 . 16587 1 85 . 1 1 23 23 PHE HE2 H 1 7.44 0.02 . 1 . . . . 22 PHE HE2 . 16587 1 86 . 1 1 23 23 PHE N N 15 119.62 0.2 . 1 . . . . 22 PHE N . 16587 1 87 . 1 1 24 24 LEU H H 1 8.94 0.02 . 1 . . . . 23 LEU HN . 16587 1 88 . 1 1 24 24 LEU HA H 1 3.72 0.02 . 1 . . . . 23 LEU HA . 16587 1 89 . 1 1 24 24 LEU HB2 H 1 -0.81 0.02 . 2 . . . . 23 LEU HB2 . 16587 1 90 . 1 1 24 24 LEU HD11 H 1 0.06 0.02 . 2 . . . . 23 LEU HD1 . 16587 1 91 . 1 1 24 24 LEU HD12 H 1 0.06 0.02 . 2 . . . . 23 LEU HD1 . 16587 1 92 . 1 1 24 24 LEU HD13 H 1 0.06 0.02 . 2 . . . . 23 LEU HD1 . 16587 1 93 . 1 1 24 24 LEU HD21 H 1 -0.58 0.02 . 2 . . . . 23 LEU HD2 . 16587 1 94 . 1 1 24 24 LEU HD22 H 1 -0.58 0.02 . 2 . . . . 23 LEU HD2 . 16587 1 95 . 1 1 24 24 LEU HD23 H 1 -0.58 0.02 . 2 . . . . 23 LEU HD2 . 16587 1 96 . 1 1 24 24 LEU HG H 1 0.71 0.02 . 1 . . . . 23 LEU HG . 16587 1 97 . 1 1 24 24 LEU N N 15 127.19 0.2 . 1 . . . . 23 LEU N . 16587 1 98 . 1 1 25 25 ASN H H 1 8.28 0.02 . 1 . . . . 24 ASN HN . 16587 1 99 . 1 1 25 25 ASN HA H 1 5.46 0.02 . 1 . . . . 24 ASN HA . 16587 1 100 . 1 1 25 25 ASN HB2 H 1 1.93 0.02 . 2 . . . . 24 ASN HB2 . 16587 1 101 . 1 1 25 25 ASN HB3 H 1 1.66 0.02 . 2 . . . . 24 ASN HB3 . 16587 1 102 . 1 1 25 25 ASN HD21 H 1 5.67 0.02 . 2 . . . . 24 ASN HD21 . 16587 1 103 . 1 1 25 25 ASN HD22 H 1 5.58 0.02 . 2 . . . . 24 ASN HD22 . 16587 1 104 . 1 1 25 25 ASN N N 15 121.71 0.2 . 1 . . . . 24 ASN N . 16587 1 105 . 1 1 25 25 ASN ND2 N 15 106.53 0.2 . 1 . . . . 24 ASN ND2 . 16587 1 106 . 1 1 26 26 CYS H H 1 9.86 0.02 . 1 . . . . 25 CYS HN . 16587 1 107 . 1 1 26 26 CYS HA H 1 5.24 0.02 . 1 . . . . 25 CYS HA . 16587 1 108 . 1 1 26 26 CYS HB2 H 1 3.43 0.02 . 2 . . . . 25 CYS HB2 . 16587 1 109 . 1 1 26 26 CYS HB3 H 1 2.65 0.02 . 2 . . . . 25 CYS HB3 . 16587 1 110 . 1 1 26 26 CYS N N 15 121.35 0.2 . 1 . . . . 25 CYS N . 16587 1 111 . 1 1 27 27 TYR H H 1 9.72 0.02 . 1 . . . . 26 TYR HN . 16587 1 112 . 1 1 27 27 TYR HA H 1 5.45 0.02 . 1 . . . . 26 TYR HA . 16587 1 113 . 1 1 27 27 TYR HB2 H 1 3.24 0.02 . 2 . . . . 26 TYR HB2 . 16587 1 114 . 1 1 27 27 TYR HB3 H 1 3.04 0.02 . 2 . . . . 26 TYR HB3 . 16587 1 115 . 1 1 27 27 TYR HD1 H 1 6.95 0.02 . 1 . . . . 26 TYR HD1 . 16587 1 116 . 1 1 27 27 TYR HD2 H 1 6.95 0.02 . 1 . . . . 26 TYR HD2 . 16587 1 117 . 1 1 27 27 TYR HE1 H 1 6.25 0.02 . 1 . . . . 26 TYR HE1 . 16587 1 118 . 1 1 27 27 TYR HE2 H 1 6.25 0.02 . 1 . . . . 26 TYR HE2 . 16587 1 119 . 1 1 27 27 TYR N N 15 131.01 0.2 . 1 . . . . 26 TYR N . 16587 1 120 . 1 1 28 28 VAL H H 1 8.73 0.02 . 1 . . . . 27 VAL HN . 16587 1 121 . 1 1 28 28 VAL HA H 1 5.04 0.02 . 1 . . . . 27 VAL HA . 16587 1 122 . 1 1 28 28 VAL HB H 1 2.09 0.02 . 1 . . . . 27 VAL HB . 16587 1 123 . 1 1 28 28 VAL HG11 H 1 1.03 0.02 . 2 . . . . 27 VAL HG1 . 16587 1 124 . 1 1 28 28 VAL HG12 H 1 1.03 0.02 . 2 . . . . 27 VAL HG1 . 16587 1 125 . 1 1 28 28 VAL HG13 H 1 1.03 0.02 . 2 . . . . 27 VAL HG1 . 16587 1 126 . 1 1 28 28 VAL HG21 H 1 0.85 0.02 . 2 . . . . 27 VAL HG2 . 16587 1 127 . 1 1 28 28 VAL HG22 H 1 0.85 0.02 . 2 . . . . 27 VAL HG2 . 16587 1 128 . 1 1 28 28 VAL HG23 H 1 0.85 0.02 . 2 . . . . 27 VAL HG2 . 16587 1 129 . 1 1 28 28 VAL N N 15 126.53 0.2 . 1 . . . . 27 VAL N . 16587 1 130 . 1 1 29 29 SER H H 1 9.07 0.02 . 1 . . . . 28 SER HN . 16587 1 131 . 1 1 29 29 SER HA H 1 5.33 0.02 . 1 . . . . 28 SER HA . 16587 1 132 . 1 1 29 29 SER HB2 H 1 3.83 0.02 . 2 . . . . 28 SER HB2 . 16587 1 133 . 1 1 29 29 SER HB3 H 1 3.63 0.02 . 2 . . . . 28 SER HB3 . 16587 1 134 . 1 1 29 29 SER N N 15 120.48 0.2 . 1 . . . . 28 SER N . 16587 1 135 . 1 1 30 30 GLY H H 1 7.75 0.02 . 1 . . . . 29 GLY HN . 16587 1 136 . 1 1 30 30 GLY HA2 H 1 3.85 0.02 . 2 . . . . 29 GLY HA1 . 16587 1 137 . 1 1 30 30 GLY HA3 H 1 3.42 0.02 . 2 . . . . 29 GLY HA2 . 16587 1 138 . 1 1 30 30 GLY N N 15 108.21 0.2 . 1 . . . . 29 GLY N . 16587 1 139 . 1 1 31 31 PHE H H 1 7.85 0.02 . 1 . . . . 30 PHE HN . 16587 1 140 . 1 1 31 31 PHE HA H 1 4.94 0.02 . 1 . . . . 30 PHE HA . 16587 1 141 . 1 1 31 31 PHE HD1 H 1 7.03 0.02 . 1 . . . . 30 PHE HD1 . 16587 1 142 . 1 1 31 31 PHE HD2 H 1 7.03 0.02 . 1 . . . . 30 PHE HD2 . 16587 1 143 . 1 1 31 31 PHE N N 15 116.9 0.2 . 1 . . . . 30 PHE N . 16587 1 144 . 1 1 36 36 ILE H H 1 7.13 0.02 . 1 . . . . 35 ILE HN . 16587 1 145 . 1 1 36 36 ILE HA H 1 5.11 0.02 . 1 . . . . 35 ILE HA . 16587 1 146 . 1 1 36 36 ILE N N 15 112.15 0.2 . 1 . . . . 35 ILE N . 16587 1 147 . 1 1 37 37 GLU H H 1 8.17 0.02 . 1 . . . . 36 GLU HN . 16587 1 148 . 1 1 37 37 GLU HA H 1 4.5 0.02 . 1 . . . . 36 GLU HA . 16587 1 149 . 1 1 37 37 GLU N N 15 122.23 0.2 . 1 . . . . 36 GLU N . 16587 1 150 . 1 1 38 38 VAL H H 1 8.1 0.02 . 1 . . . . 37 VAL HN . 16587 1 151 . 1 1 38 38 VAL HA H 1 4.8 0.02 . 1 . . . . 37 VAL HA . 16587 1 152 . 1 1 38 38 VAL HB H 1 0.53 0.02 . 1 . . . . 37 VAL HB . 16587 1 153 . 1 1 38 38 VAL HG11 H 1 0.67 0.02 . 2 . . . . 37 VAL HG1 . 16587 1 154 . 1 1 38 38 VAL HG12 H 1 0.67 0.02 . 2 . . . . 37 VAL HG1 . 16587 1 155 . 1 1 38 38 VAL HG13 H 1 0.67 0.02 . 2 . . . . 37 VAL HG1 . 16587 1 156 . 1 1 38 38 VAL HG21 H 1 0.21 0.02 . 2 . . . . 37 VAL HG2 . 16587 1 157 . 1 1 38 38 VAL HG22 H 1 0.21 0.02 . 2 . . . . 37 VAL HG2 . 16587 1 158 . 1 1 38 38 VAL HG23 H 1 0.21 0.02 . 2 . . . . 37 VAL HG2 . 16587 1 159 . 1 1 38 38 VAL N N 15 126.17 0.2 . 1 . . . . 37 VAL N . 16587 1 160 . 1 1 39 39 ASP H H 1 8.94 0.02 . 1 . . . . 38 ASP HN . 16587 1 161 . 1 1 39 39 ASP HA H 1 5.07 0.02 . 1 . . . . 38 ASP HA . 16587 1 162 . 1 1 39 39 ASP HB2 H 1 2.48 0.02 . 2 . . . . 38 ASP HB2 . 16587 1 163 . 1 1 39 39 ASP HB3 H 1 2.19 0.02 . 2 . . . . 38 ASP HB3 . 16587 1 164 . 1 1 39 39 ASP N N 15 123.38 0.2 . 1 . . . . 38 ASP N . 16587 1 165 . 1 1 40 40 LEU H H 1 8.93 0.02 . 1 . . . . 39 LEU HN . 16587 1 166 . 1 1 40 40 LEU HA H 1 5.11 0.02 . 1 . . . . 39 LEU HA . 16587 1 167 . 1 1 40 40 LEU HD11 H 1 0.77 0.02 . 1 . . . . 39 LEU HD1 . 16587 1 168 . 1 1 40 40 LEU HD12 H 1 0.77 0.02 . 1 . . . . 39 LEU HD1 . 16587 1 169 . 1 1 40 40 LEU HD13 H 1 0.77 0.02 . 1 . . . . 39 LEU HD1 . 16587 1 170 . 1 1 40 40 LEU HD21 H 1 0.77 0.02 . 1 . . . . 39 LEU HD2 . 16587 1 171 . 1 1 40 40 LEU HD22 H 1 0.77 0.02 . 1 . . . . 39 LEU HD2 . 16587 1 172 . 1 1 40 40 LEU HD23 H 1 0.77 0.02 . 1 . . . . 39 LEU HD2 . 16587 1 173 . 1 1 40 40 LEU N N 15 120.64 0.2 . 1 . . . . 39 LEU N . 16587 1 174 . 1 1 41 41 LEU HB2 H 1 0.89 0.02 . 2 . . . . 40 LEU HB2 . 16587 1 175 . 1 1 42 42 LYS HA H 1 4.5 0.02 . 1 . . . . 41 LYS HA . 16587 1 176 . 1 1 45 45 GLU H H 1 7.86 0.02 . 1 . . . . 44 GLU HN . 16587 1 177 . 1 1 45 45 GLU N N 15 120.31 0.2 . 1 . . . . 44 GLU N . 16587 1 178 . 1 1 46 46 ARG H H 1 8.65 0.02 . 1 . . . . 45 ARG HN . 16587 1 179 . 1 1 46 46 ARG HE H 1 7.47 0.02 . 1 . . . . 45 ARG HE . 16587 1 180 . 1 1 46 46 ARG N N 15 123.91 0.2 . 1 . . . . 45 ARG N . 16587 1 181 . 1 1 47 47 ILE H H 1 8.86 0.02 . 1 . . . . 46 ILE HN . 16587 1 182 . 1 1 47 47 ILE HA H 1 4.02 0.02 . 1 . . . . 46 ILE HA . 16587 1 183 . 1 1 47 47 ILE HB H 1 1.65 0.02 . 1 . . . . 46 ILE HB . 16587 1 184 . 1 1 47 47 ILE HG21 H 1 1.01 0.02 . 1 . . . . 46 ILE HG2 . 16587 1 185 . 1 1 47 47 ILE HG22 H 1 1.01 0.02 . 1 . . . . 46 ILE HG2 . 16587 1 186 . 1 1 47 47 ILE HG23 H 1 1.01 0.02 . 1 . . . . 46 ILE HG2 . 16587 1 187 . 1 1 48 48 GLU H H 1 8.54 0.02 . 1 . . . . 47 GLU HN . 16587 1 188 . 1 1 48 48 GLU HA H 1 4.18 0.02 . 1 . . . . 47 GLU HA . 16587 1 189 . 1 1 48 48 GLU HB2 H 1 2.08 0.02 . 2 . . . . 47 GLU HB2 . 16587 1 190 . 1 1 48 48 GLU HG2 H 1 2.37 0.02 . 2 . . . . 47 GLU HG2 . 16587 1 191 . 1 1 48 48 GLU N N 15 126.31 0.2 . 1 . . . . 47 GLU N . 16587 1 192 . 1 1 49 49 LYS H H 1 7.92 0.02 . 1 . . . . 48 LYS HN . 16587 1 193 . 1 1 49 49 LYS HA H 1 4.53 0.02 . 1 . . . . 48 LYS HA . 16587 1 194 . 1 1 49 49 LYS HB2 H 1 1.96 0.02 . 1 . . . . 48 LYS HB2 . 16587 1 195 . 1 1 49 49 LYS HB3 H 1 1.8 0.02 . 1 . . . . 48 LYS HB3 . 16587 1 196 . 1 1 49 49 LYS HG2 H 1 1.43 0.02 . 2 . . . . 48 LYS HG2 . 16587 1 197 . 1 1 49 49 LYS N N 15 119.3 0.2 . 1 . . . . 48 LYS N . 16587 1 198 . 1 1 50 50 VAL H H 1 7.84 0.02 . 1 . . . . 49 VAL HN . 16587 1 199 . 1 1 50 50 VAL HA H 1 4.35 0.02 . 1 . . . . 49 VAL HA . 16587 1 200 . 1 1 50 50 VAL HB H 1 2.06 0.02 . 1 . . . . 49 VAL HB . 16587 1 201 . 1 1 50 50 VAL HG11 H 1 1.14 0.02 . 2 . . . . 49 VAL HG1 . 16587 1 202 . 1 1 50 50 VAL HG12 H 1 1.14 0.02 . 2 . . . . 49 VAL HG1 . 16587 1 203 . 1 1 50 50 VAL HG13 H 1 1.14 0.02 . 2 . . . . 49 VAL HG1 . 16587 1 204 . 1 1 50 50 VAL HG21 H 1 1.02 0.02 . 2 . . . . 49 VAL HG2 . 16587 1 205 . 1 1 50 50 VAL HG22 H 1 1.02 0.02 . 2 . . . . 49 VAL HG2 . 16587 1 206 . 1 1 50 50 VAL HG23 H 1 1.02 0.02 . 2 . . . . 49 VAL HG2 . 16587 1 207 . 1 1 50 50 VAL N N 15 124.07 0.2 . 1 . . . . 49 VAL N . 16587 1 208 . 1 1 51 51 GLU H H 1 8.45 0.02 . 1 . . . . 50 GLU HN . 16587 1 209 . 1 1 51 51 GLU HA H 1 4.5 0.02 . 1 . . . . 50 GLU HA . 16587 1 210 . 1 1 51 51 GLU HB2 H 1 1.66 0.02 . 2 . . . . 50 GLU HB2 . 16587 1 211 . 1 1 51 51 GLU HB3 H 1 0.95 0.02 . 2 . . . . 50 GLU HB3 . 16587 1 212 . 1 1 51 51 GLU HG2 H 1 2.11 0.02 . 1 . . . . 50 GLU HG2 . 16587 1 213 . 1 1 51 51 GLU HG3 H 1 2.11 0.02 . 1 . . . . 50 GLU HG3 . 16587 1 214 . 1 1 51 51 GLU N N 15 126.6 0.2 . 1 . . . . 50 GLU N . 16587 1 215 . 1 1 52 52 HIS H H 1 8.1 0.02 . 1 . . . . 51 HIS HN . 16587 1 216 . 1 1 52 52 HIS HA H 1 5.63 0.02 . 1 . . . . 51 HIS HA . 16587 1 217 . 1 1 52 52 HIS HB2 H 1 2.41 0.02 . 2 . . . . 51 HIS HB2 . 16587 1 218 . 1 1 52 52 HIS HB3 H 1 2.12 0.02 . 2 . . . . 51 HIS HB3 . 16587 1 219 . 1 1 52 52 HIS HD1 H 1 7.06 0.02 . 1 . . . . 51 HIS HD1 . 16587 1 220 . 1 1 52 52 HIS N N 15 111.73 0.2 . 1 . . . . 51 HIS N . 16587 1 221 . 1 1 53 53 SER H H 1 9.15 0.02 . 1 . . . . 52 SER HN . 16587 1 222 . 1 1 53 53 SER HA H 1 4.66 0.02 . 1 . . . . 52 SER HA . 16587 1 223 . 1 1 53 53 SER HB2 H 1 4.48 0.02 . 2 . . . . 52 SER HB2 . 16587 1 224 . 1 1 53 53 SER HB3 H 1 4.02 0.02 . 2 . . . . 52 SER HB3 . 16587 1 225 . 1 1 53 53 SER N N 15 117 0.2 . 1 . . . . 52 SER N . 16587 1 226 . 1 1 54 54 ASP H H 1 8.46 0.02 . 1 . . . . 53 ASP HN . 16587 1 227 . 1 1 54 54 ASP HA H 1 4.85 0.02 . 1 . . . . 53 ASP HA . 16587 1 228 . 1 1 54 54 ASP HB2 H 1 2.79 0.02 . 2 . . . . 53 ASP HB2 . 16587 1 229 . 1 1 54 54 ASP HB3 H 1 2.56 0.02 . 2 . . . . 53 ASP HB3 . 16587 1 230 . 1 1 54 54 ASP N N 15 119.27 0.2 . 1 . . . . 53 ASP N . 16587 1 231 . 1 1 55 55 LEU H H 1 8.54 0.02 . 1 . . . . 54 LEU HN . 16587 1 232 . 1 1 55 55 LEU HA H 1 4.17 0.02 . 1 . . . . 54 LEU HA . 16587 1 233 . 1 1 55 55 LEU HB2 H 1 1.62 0.02 . 1 . . . . 54 LEU HB2 . 16587 1 234 . 1 1 55 55 LEU HB3 H 1 1.62 0.02 . 1 . . . . 54 LEU HB3 . 16587 1 235 . 1 1 55 55 LEU HD11 H 1 0.8 0.02 . 2 . . . . 54 LEU HD1 . 16587 1 236 . 1 1 55 55 LEU HD12 H 1 0.8 0.02 . 2 . . . . 54 LEU HD1 . 16587 1 237 . 1 1 55 55 LEU HD13 H 1 0.8 0.02 . 2 . . . . 54 LEU HD1 . 16587 1 238 . 1 1 55 55 LEU HD21 H 1 0.65 0.02 . 2 . . . . 54 LEU HD2 . 16587 1 239 . 1 1 55 55 LEU HD22 H 1 0.65 0.02 . 2 . . . . 54 LEU HD2 . 16587 1 240 . 1 1 55 55 LEU HD23 H 1 0.65 0.02 . 2 . . . . 54 LEU HD2 . 16587 1 241 . 1 1 55 55 LEU HG H 1 1.4 0.02 . 1 . . . . 54 LEU HG . 16587 1 242 . 1 1 55 55 LEU N N 15 125.25 0.2 . 1 . . . . 54 LEU N . 16587 1 243 . 1 1 56 56 SER H H 1 8.22 0.02 . 1 . . . . 55 SER HN . 16587 1 244 . 1 1 56 56 SER HB2 H 1 3.35 0.02 . 2 . . . . 55 SER HB2 . 16587 1 245 . 1 1 56 56 SER HB3 H 1 2.68 0.02 . 2 . . . . 55 SER HB3 . 16587 1 246 . 1 1 56 56 SER N N 15 121.36 0.2 . 1 . . . . 55 SER N . 16587 1 247 . 1 1 57 57 PHE H H 1 8.1 0.02 . 1 . . . . 56 PHE HN . 16587 1 248 . 1 1 57 57 PHE HA H 1 5.31 0.02 . 1 . . . . 56 PHE HA . 16587 1 249 . 1 1 57 57 PHE HB2 H 1 3.05 0.02 . 2 . . . . 56 PHE HB2 . 16587 1 250 . 1 1 57 57 PHE HB3 H 1 2.75 0.02 . 2 . . . . 56 PHE HB3 . 16587 1 251 . 1 1 57 57 PHE HD1 H 1 7.13 0.02 . 1 . . . . 56 PHE HD1 . 16587 1 252 . 1 1 57 57 PHE HD2 H 1 7.13 0.02 . 1 . . . . 56 PHE HD2 . 16587 1 253 . 1 1 57 57 PHE N N 15 119.21 0.2 . 1 . . . . 56 PHE N . 16587 1 254 . 1 1 58 58 SER H H 1 9 0.02 . 1 . . . . 57 SER HN . 16587 1 255 . 1 1 58 58 SER HA H 1 4.87 0.02 . 1 . . . . 57 SER HA . 16587 1 256 . 1 1 58 58 SER HB2 H 1 4.12 0.02 . 2 . . . . 57 SER HB2 . 16587 1 257 . 1 1 58 58 SER HB3 H 1 3.97 0.02 . 2 . . . . 57 SER HB3 . 16587 1 258 . 1 1 58 58 SER N N 15 119.36 0.2 . 1 . . . . 57 SER N . 16587 1 259 . 1 1 59 59 LYS HA H 1 4.16 0.02 . 1 . . . . 58 LYS HA . 16587 1 260 . 1 1 59 59 LYS HB2 H 1 1.87 0.02 . 1 . . . . 58 LYS HB2 . 16587 1 261 . 1 1 59 59 LYS HB3 H 1 1.87 0.02 . 1 . . . . 58 LYS HB3 . 16587 1 262 . 1 1 59 59 LYS HG2 H 1 1.49 0.02 . 1 . . . . 58 LYS HG2 . 16587 1 263 . 1 1 59 59 LYS HG3 H 1 1.49 0.02 . 1 . . . . 58 LYS HG3 . 16587 1 264 . 1 1 60 60 ASP H H 1 7.91 0.02 . 1 . . . . 59 ASP HN . 16587 1 265 . 1 1 60 60 ASP HA H 1 4.58 0.02 . 1 . . . . 59 ASP HA . 16587 1 266 . 1 1 60 60 ASP HB2 H 1 2.99 0.02 . 2 . . . . 59 ASP HB2 . 16587 1 267 . 1 1 60 60 ASP HB3 H 1 2.63 0.02 . 2 . . . . 59 ASP HB3 . 16587 1 268 . 1 1 60 60 ASP N N 15 115.83 0.2 . 1 . . . . 59 ASP N . 16587 1 269 . 1 1 61 61 GLY H H 1 8.07 0.02 . 1 . . . . 60 GLY HN . 16587 1 270 . 1 1 61 61 GLY HA2 H 1 4.31 0.02 . 2 . . . . 60 GLY HA1 . 16587 1 271 . 1 1 61 61 GLY HA3 H 1 3.66 0.02 . 2 . . . . 60 GLY HA2 . 16587 1 272 . 1 1 61 61 GLY N N 15 107.97 0.2 . 1 . . . . 60 GLY N . 16587 1 273 . 1 1 62 62 SER H H 1 7.84 0.02 . 1 . . . . 61 SER HN . 16587 1 274 . 1 1 62 62 SER HA H 1 4.51 0.02 . 1 . . . . 61 SER HA . 16587 1 275 . 1 1 62 62 SER HB2 H 1 3.83 0.02 . 2 . . . . 61 SER HB2 . 16587 1 276 . 1 1 62 62 SER HB3 H 1 3.74 0.02 . 2 . . . . 61 SER HB3 . 16587 1 277 . 1 1 62 62 SER N N 15 115.72 0.2 . 1 . . . . 61 SER N . 16587 1 278 . 1 1 63 63 PHE H H 1 8.16 0.02 . 1 . . . . 62 PHE HN . 16587 1 279 . 1 1 63 63 PHE HA H 1 5.59 0.02 . 1 . . . . 62 PHE HA . 16587 1 280 . 1 1 63 63 PHE HB2 H 1 2.75 0.02 . 2 . . . . 62 PHE HB2 . 16587 1 281 . 1 1 63 63 PHE HD1 H 1 7.13 0.02 . 1 . . . . 62 PHE HD1 . 16587 1 282 . 1 1 63 63 PHE HD2 H 1 7.13 0.02 . 1 . . . . 62 PHE HD2 . 16587 1 283 . 1 1 63 63 PHE N N 15 119.35 0.2 . 1 . . . . 62 PHE N . 16587 1 284 . 1 1 64 64 TYR H H 1 8.93 0.02 . 1 . . . . 63 TYR HN . 16587 1 285 . 1 1 64 64 TYR HA H 1 5.37 0.02 . 1 . . . . 63 TYR HA . 16587 1 286 . 1 1 64 64 TYR HB2 H 1 2.7 0.02 . 2 . . . . 63 TYR HB2 . 16587 1 287 . 1 1 64 64 TYR HB3 H 1 2.38 0.02 . 2 . . . . 63 TYR HB3 . 16587 1 288 . 1 1 64 64 TYR HD1 H 1 6.7 0.02 . 1 . . . . 63 TYR HD1 . 16587 1 289 . 1 1 64 64 TYR HD2 H 1 6.7 0.02 . 1 . . . . 63 TYR HD2 . 16587 1 290 . 1 1 64 64 TYR N N 15 118.66 0.2 . 1 . . . . 63 TYR N . 16587 1 291 . 1 1 65 65 LEU H H 1 8.62 0.02 . 1 . . . . 64 LEU HN . 16587 1 292 . 1 1 65 65 LEU HA H 1 4.4 0.02 . 1 . . . . 64 LEU HA . 16587 1 293 . 1 1 65 65 LEU HD11 H 1 1.04 0.02 . 2 . . . . 64 LEU HD1 . 16587 1 294 . 1 1 65 65 LEU HD12 H 1 1.04 0.02 . 2 . . . . 64 LEU HD1 . 16587 1 295 . 1 1 65 65 LEU HD13 H 1 1.04 0.02 . 2 . . . . 64 LEU HD1 . 16587 1 296 . 1 1 65 65 LEU HD21 H 1 0.83 0.02 . 2 . . . . 64 LEU HD2 . 16587 1 297 . 1 1 65 65 LEU HD22 H 1 0.83 0.02 . 2 . . . . 64 LEU HD2 . 16587 1 298 . 1 1 65 65 LEU HD23 H 1 0.83 0.02 . 2 . . . . 64 LEU HD2 . 16587 1 299 . 1 1 65 65 LEU N N 15 119.18 0.2 . 1 . . . . 64 LEU N . 16587 1 300 . 1 1 66 66 LEU H H 1 8.08 0.02 . 1 . . . . 65 LEU HN . 16587 1 301 . 1 1 66 66 LEU HA H 1 5.46 0.02 . 1 . . . . 65 LEU HA . 16587 1 302 . 1 1 66 66 LEU HB2 H 1 1.8 0.02 . 1 . . . . 65 LEU HB2 . 16587 1 303 . 1 1 66 66 LEU HB3 H 1 1.8 0.02 . 1 . . . . 65 LEU HB3 . 16587 1 304 . 1 1 66 66 LEU HD11 H 1 1.03 0.02 . 2 . . . . 65 LEU HD1 . 16587 1 305 . 1 1 66 66 LEU HD12 H 1 1.03 0.02 . 2 . . . . 65 LEU HD1 . 16587 1 306 . 1 1 66 66 LEU HD13 H 1 1.03 0.02 . 2 . . . . 65 LEU HD1 . 16587 1 307 . 1 1 66 66 LEU HD21 H 1 0.82 0.02 . 2 . . . . 65 LEU HD2 . 16587 1 308 . 1 1 66 66 LEU HD22 H 1 0.82 0.02 . 2 . . . . 65 LEU HD2 . 16587 1 309 . 1 1 66 66 LEU HD23 H 1 0.82 0.02 . 2 . . . . 65 LEU HD2 . 16587 1 310 . 1 1 66 66 LEU HG H 1 1.63 0.02 . 1 . . . . 65 LEU HG . 16587 1 311 . 1 1 66 66 LEU N N 15 121.07 0.2 . 1 . . . . 65 LEU N . 16587 1 312 . 1 1 67 67 TYR H H 1 9.18 0.02 . 1 . . . . 66 TYR HN . 16587 1 313 . 1 1 67 67 TYR HA H 1 5.31 0.02 . 1 . . . . 66 TYR HA . 16587 1 314 . 1 1 67 67 TYR HB2 H 1 2.91 0.02 . 2 . . . . 66 TYR HB2 . 16587 1 315 . 1 1 67 67 TYR HB3 H 1 2.66 0.02 . 2 . . . . 66 TYR HB3 . 16587 1 316 . 1 1 67 67 TYR HD1 H 1 7.05 0.02 . 1 . . . . 66 TYR HD1 . 16587 1 317 . 1 1 67 67 TYR HD2 H 1 7.05 0.02 . 1 . . . . 66 TYR HD2 . 16587 1 318 . 1 1 67 67 TYR HE1 H 1 6.59 0.02 . 1 . . . . 66 TYR HE1 . 16587 1 319 . 1 1 67 67 TYR HE2 H 1 6.59 0.02 . 1 . . . . 66 TYR HE2 . 16587 1 320 . 1 1 67 67 TYR N N 15 125.78 0.2 . 1 . . . . 66 TYR N . 16587 1 321 . 1 1 68 68 TYR H H 1 8.98 0.02 . 1 . . . . 67 TYR HN . 16587 1 322 . 1 1 68 68 TYR HA H 1 6.09 0.02 . 1 . . . . 67 TYR HA . 16587 1 323 . 1 1 68 68 TYR HB2 H 1 3.2 0.02 . 2 . . . . 67 TYR HB2 . 16587 1 324 . 1 1 68 68 TYR HB3 H 1 2.75 0.02 . 2 . . . . 67 TYR HB3 . 16587 1 325 . 1 1 68 68 TYR HD1 H 1 6.71 0.02 . 1 . . . . 67 TYR HD1 . 16587 1 326 . 1 1 68 68 TYR HD2 H 1 6.71 0.02 . 1 . . . . 67 TYR HD2 . 16587 1 327 . 1 1 68 68 TYR HE1 H 1 6.55 0.02 . 1 . . . . 67 TYR HE1 . 16587 1 328 . 1 1 68 68 TYR HE2 H 1 6.55 0.02 . 1 . . . . 67 TYR HE2 . 16587 1 329 . 1 1 68 68 TYR N N 15 117.75 0.2 . 1 . . . . 67 TYR N . 16587 1 330 . 1 1 69 69 THR H H 1 8.26 0.02 . 1 . . . . 68 THR HN . 16587 1 331 . 1 1 69 69 THR HA H 1 4.86 0.02 . 1 . . . . 68 THR HA . 16587 1 332 . 1 1 69 69 THR HB H 1 4.14 0.02 . 1 . . . . 68 THR HB . 16587 1 333 . 1 1 69 69 THR HG21 H 1 0.98 0.02 . 1 . . . . 68 THR HG2 . 16587 1 334 . 1 1 69 69 THR HG22 H 1 0.98 0.02 . 1 . . . . 68 THR HG2 . 16587 1 335 . 1 1 69 69 THR HG23 H 1 0.98 0.02 . 1 . . . . 68 THR HG2 . 16587 1 336 . 1 1 69 69 THR N N 15 111.4 0.2 . 1 . . . . 68 THR N . 16587 1 337 . 1 1 70 70 GLU H H 1 8.26 0.02 . 1 . . . . 69 GLU HN . 16587 1 338 . 1 1 70 70 GLU HA H 1 4.41 0.02 . 1 . . . . 69 GLU HA . 16587 1 339 . 1 1 70 70 GLU HB2 H 1 1.96 0.02 . 2 . . . . 69 GLU HB2 . 16587 1 340 . 1 1 70 70 GLU HB3 H 1 1.79 0.02 . 2 . . . . 69 GLU HB3 . 16587 1 341 . 1 1 70 70 GLU HG2 H 1 2.01 0.02 . 1 . . . . 69 GLU HG2 . 16587 1 342 . 1 1 70 70 GLU HG3 H 1 2.01 0.02 . 1 . . . . 69 GLU HG3 . 16587 1 343 . 1 1 70 70 GLU N N 15 128.88 0.2 . 1 . . . . 69 GLU N . 16587 1 344 . 1 1 71 71 PHE H H 1 8.75 0.02 . 1 . . . . 70 PHE HN . 16587 1 345 . 1 1 71 71 PHE HA H 1 4.87 0.02 . 1 . . . . 70 PHE HA . 16587 1 346 . 1 1 71 71 PHE HB3 H 1 2.78 0.02 . 2 . . . . 70 PHE HB3 . 16587 1 347 . 1 1 71 71 PHE HD1 H 1 6.25 0.02 . 1 . . . . 70 PHE HD1 . 16587 1 348 . 1 1 71 71 PHE HD2 H 1 6.25 0.02 . 1 . . . . 70 PHE HD2 . 16587 1 349 . 1 1 71 71 PHE HE1 H 1 6.25 0.02 . 1 . . . . 70 PHE HE1 . 16587 1 350 . 1 1 71 71 PHE HE2 H 1 6.25 0.02 . 1 . . . . 70 PHE HE2 . 16587 1 351 . 1 1 71 71 PHE HZ H 1 5.86 0.02 . 1 . . . . 70 PHE HZ . 16587 1 352 . 1 1 71 71 PHE N N 15 125.07 0.2 . 1 . . . . 70 PHE N . 16587 1 353 . 1 1 72 72 THR HG21 H 1 0.89 0.02 . 1 . . . . 71 THR HG2 . 16587 1 354 . 1 1 72 72 THR HG22 H 1 0.89 0.02 . 1 . . . . 71 THR HG2 . 16587 1 355 . 1 1 72 72 THR HG23 H 1 0.89 0.02 . 1 . . . . 71 THR HG2 . 16587 1 356 . 1 1 73 73 PRO HB2 H 1 2.32 0.02 . 2 . . . . 72 PRO HB2 . 16587 1 357 . 1 1 73 73 PRO HB3 H 1 2.12 0.02 . 2 . . . . 72 PRO HB3 . 16587 1 358 . 1 1 73 73 PRO HG2 H 1 1.86 0.02 . 2 . . . . 72 PRO HG2 . 16587 1 359 . 1 1 74 74 THR HG21 H 1 1.36 0.02 . 1 . . . . 73 THR HG2 . 16587 1 360 . 1 1 74 74 THR HG22 H 1 1.36 0.02 . 1 . . . . 73 THR HG2 . 16587 1 361 . 1 1 74 74 THR HG23 H 1 1.36 0.02 . 1 . . . . 73 THR HG2 . 16587 1 362 . 1 1 79 79 TYR H H 1 9.46 0.02 . 1 . . . . 78 TYR HN . 16587 1 363 . 1 1 79 79 TYR HA H 1 5.72 0.02 . 1 . . . . 78 TYR HA . 16587 1 364 . 1 1 79 79 TYR HB3 H 1 2.82 0.02 . 2 . . . . 78 TYR HB3 . 16587 1 365 . 1 1 79 79 TYR HD1 H 1 7.16 0.02 . 1 . . . . 78 TYR HD1 . 16587 1 366 . 1 1 79 79 TYR HD2 H 1 7.16 0.02 . 1 . . . . 78 TYR HD2 . 16587 1 367 . 1 1 79 79 TYR N N 15 122.6 0.2 . 1 . . . . 78 TYR N . 16587 1 368 . 1 1 80 80 ALA H H 1 8.75 0.02 . 1 . . . . 79 ALA HN . 16587 1 369 . 1 1 80 80 ALA HA H 1 5.11 0.02 . 1 . . . . 79 ALA HA . 16587 1 370 . 1 1 80 80 ALA HB1 H 1 1.24 0.02 . 1 . . . . 79 ALA HB . 16587 1 371 . 1 1 80 80 ALA HB2 H 1 1.24 0.02 . 1 . . . . 79 ALA HB . 16587 1 372 . 1 1 80 80 ALA HB3 H 1 1.24 0.02 . 1 . . . . 79 ALA HB . 16587 1 373 . 1 1 80 80 ALA N N 15 120.24 0.2 . 1 . . . . 79 ALA N . 16587 1 374 . 1 1 81 81 CYS H H 1 9.18 0.02 . 1 . . . . 80 CYS HN . 16587 1 375 . 1 1 81 81 CYS HA H 1 5.14 0.02 . 1 . . . . 80 CYS HA . 16587 1 376 . 1 1 81 81 CYS HB2 H 1 3.09 0.02 . 2 . . . . 80 CYS HB2 . 16587 1 377 . 1 1 81 81 CYS HB3 H 1 2.67 0.02 . 2 . . . . 80 CYS HB3 . 16587 1 378 . 1 1 81 81 CYS N N 15 120 0.2 . 1 . . . . 80 CYS N . 16587 1 379 . 1 1 82 82 ARG H H 1 9.41 0.02 . 1 . . . . 81 ARG HN . 16587 1 380 . 1 1 82 82 ARG HA H 1 5.41 0.02 . 1 . . . . 81 ARG HA . 16587 1 381 . 1 1 82 82 ARG HB2 H 1 1.87 0.02 . 2 . . . . 81 ARG HB2 . 16587 1 382 . 1 1 82 82 ARG HE H 1 7.37 0.02 . 1 . . . . 81 ARG HE . 16587 1 383 . 1 1 82 82 ARG N N 15 128.36 0.2 . 1 . . . . 81 ARG N . 16587 1 384 . 1 1 83 83 VAL H H 1 9.11 0.02 . 1 . . . . 82 VAL HN . 16587 1 385 . 1 1 83 83 VAL HA H 1 4.63 0.02 . 1 . . . . 82 VAL HA . 16587 1 386 . 1 1 83 83 VAL HB H 1 1.74 0.02 . 1 . . . . 82 VAL HB . 16587 1 387 . 1 1 83 83 VAL HG11 H 1 0.83 0.02 . 2 . . . . 82 VAL HG1 . 16587 1 388 . 1 1 83 83 VAL HG12 H 1 0.83 0.02 . 2 . . . . 82 VAL HG1 . 16587 1 389 . 1 1 83 83 VAL HG13 H 1 0.83 0.02 . 2 . . . . 82 VAL HG1 . 16587 1 390 . 1 1 83 83 VAL HG21 H 1 0.58 0.02 . 2 . . . . 82 VAL HG2 . 16587 1 391 . 1 1 83 83 VAL HG22 H 1 0.58 0.02 . 2 . . . . 82 VAL HG2 . 16587 1 392 . 1 1 83 83 VAL HG23 H 1 0.58 0.02 . 2 . . . . 82 VAL HG2 . 16587 1 393 . 1 1 83 83 VAL N N 15 127.38 0.2 . 1 . . . . 82 VAL N . 16587 1 394 . 1 1 84 84 ASN H H 1 8.95 0.02 . 1 . . . . 83 ASN HN . 16587 1 395 . 1 1 84 84 ASN HA H 1 5.17 0.02 . 1 . . . . 83 ASN HA . 16587 1 396 . 1 1 84 84 ASN HB2 H 1 2.81 0.02 . 2 . . . . 83 ASN HB2 . 16587 1 397 . 1 1 84 84 ASN HB3 H 1 2.37 0.02 . 2 . . . . 83 ASN HB3 . 16587 1 398 . 1 1 84 84 ASN N N 15 124.51 0.2 . 1 . . . . 83 ASN N . 16587 1 399 . 1 1 85 85 HIS H H 1 8.07 0.02 . 1 . . . . 84 HIS HN . 16587 1 400 . 1 1 85 85 HIS HA H 1 4.89 0.02 . 1 . . . . 84 HIS HA . 16587 1 401 . 1 1 85 85 HIS HB2 H 1 2.75 0.02 . 2 . . . . 84 HIS HB2 . 16587 1 402 . 1 1 85 85 HIS HB3 H 1 2.4 0.02 . 2 . . . . 84 HIS HB3 . 16587 1 403 . 1 1 85 85 HIS N N 15 123.07 0.2 . 1 . . . . 84 HIS N . 16587 1 404 . 1 1 86 86 VAL H H 1 7.69 0.02 . 1 . . . . 85 VAL HN . 16587 1 405 . 1 1 86 86 VAL HA H 1 3.96 0.02 . 1 . . . . 85 VAL HA . 16587 1 406 . 1 1 86 86 VAL HB H 1 2.07 0.02 . 1 . . . . 85 VAL HB . 16587 1 407 . 1 1 86 86 VAL HG11 H 1 0.87 0.02 . 2 . . . . 85 VAL HG1 . 16587 1 408 . 1 1 86 86 VAL HG12 H 1 0.87 0.02 . 2 . . . . 85 VAL HG1 . 16587 1 409 . 1 1 86 86 VAL HG13 H 1 0.87 0.02 . 2 . . . . 85 VAL HG1 . 16587 1 410 . 1 1 86 86 VAL N N 15 124.17 0.2 . 1 . . . . 85 VAL N . 16587 1 411 . 1 1 87 87 THR H H 1 8.96 0.02 . 1 . . . . 86 THR HN . 16587 1 412 . 1 1 87 87 THR HA H 1 4.39 0.02 . 1 . . . . 86 THR HA . 16587 1 413 . 1 1 87 87 THR HB H 1 4.45 0.02 . 1 . . . . 86 THR HB . 16587 1 414 . 1 1 87 87 THR HG21 H 1 1.42 0.02 . 1 . . . . 86 THR HG2 . 16587 1 415 . 1 1 87 87 THR HG22 H 1 1.42 0.02 . 1 . . . . 86 THR HG2 . 16587 1 416 . 1 1 87 87 THR HG23 H 1 1.42 0.02 . 1 . . . . 86 THR HG2 . 16587 1 417 . 1 1 87 87 THR N N 15 113.06 0.2 . 1 . . . . 86 THR N . 16587 1 418 . 1 1 88 88 LEU H H 1 8.02 0.02 . 1 . . . . 87 LEU HN . 16587 1 419 . 1 1 88 88 LEU HA H 1 4.96 0.02 . 1 . . . . 87 LEU HA . 16587 1 420 . 1 1 88 88 LEU HD11 H 1 0.93 0.02 . 1 . . . . 87 LEU HD1 . 16587 1 421 . 1 1 88 88 LEU HD12 H 1 0.93 0.02 . 1 . . . . 87 LEU HD1 . 16587 1 422 . 1 1 88 88 LEU HD13 H 1 0.93 0.02 . 1 . . . . 87 LEU HD1 . 16587 1 423 . 1 1 88 88 LEU HD21 H 1 0.93 0.02 . 1 . . . . 87 LEU HD2 . 16587 1 424 . 1 1 88 88 LEU HD22 H 1 0.93 0.02 . 1 . . . . 87 LEU HD2 . 16587 1 425 . 1 1 88 88 LEU HD23 H 1 0.93 0.02 . 1 . . . . 87 LEU HD2 . 16587 1 426 . 1 1 88 88 LEU N N 15 122.14 0.2 . 1 . . . . 87 LEU N . 16587 1 427 . 1 1 89 89 SER HA H 1 4.32 0.02 . 1 . . . . 88 SER HA . 16587 1 428 . 1 1 89 89 SER HB2 H 1 3.99 0.02 . 1 . . . . 88 SER HB2 . 16587 1 429 . 1 1 89 89 SER HB3 H 1 3.99 0.02 . 1 . . . . 88 SER HB3 . 16587 1 430 . 1 1 90 90 GLN H H 1 7.57 0.02 . 1 . . . . 89 GLN HN . 16587 1 431 . 1 1 90 90 GLN HA H 1 4.84 0.02 . 1 . . . . 89 GLN HA . 16587 1 432 . 1 1 90 90 GLN HB2 H 1 2.15 0.02 . 2 . . . . 89 GLN HB2 . 16587 1 433 . 1 1 90 90 GLN HB3 H 1 1.91 0.02 . 2 . . . . 89 GLN HB3 . 16587 1 434 . 1 1 90 90 GLN HG2 H 1 2.37 0.02 . 2 . . . . 89 GLN HG2 . 16587 1 435 . 1 1 90 90 GLN N N 15 118.05 0.2 . 1 . . . . 89 GLN N . 16587 1 436 . 1 1 91 91 PRO HD2 H 1 3.72 0.02 . 2 . . . . 90 PRO HD2 . 16587 1 437 . 1 1 93 93 ILE H H 1 8.42 0.02 . 1 . . . . 92 ILE HN . 16587 1 438 . 1 1 93 93 ILE HA H 1 4.89 0.02 . 1 . . . . 92 ILE HA . 16587 1 439 . 1 1 93 93 ILE HB H 1 1.73 0.02 . 1 . . . . 92 ILE HB . 16587 1 440 . 1 1 94 94 VAL H H 1 9.04 0.02 . 1 . . . . 93 VAL HN . 16587 1 441 . 1 1 94 94 VAL HA H 1 4.38 0.02 . 1 . . . . 93 VAL HA . 16587 1 442 . 1 1 94 94 VAL HB H 1 1.92 0.02 . 1 . . . . 93 VAL HB . 16587 1 443 . 1 1 94 94 VAL HG11 H 1 1.11 0.02 . 2 . . . . 93 VAL HG1 . 16587 1 444 . 1 1 94 94 VAL HG12 H 1 1.11 0.02 . 2 . . . . 93 VAL HG1 . 16587 1 445 . 1 1 94 94 VAL HG13 H 1 1.11 0.02 . 2 . . . . 93 VAL HG1 . 16587 1 446 . 1 1 94 94 VAL HG21 H 1 0.97 0.02 . 2 . . . . 93 VAL HG2 . 16587 1 447 . 1 1 94 94 VAL HG22 H 1 0.97 0.02 . 2 . . . . 93 VAL HG2 . 16587 1 448 . 1 1 94 94 VAL HG23 H 1 0.97 0.02 . 2 . . . . 93 VAL HG2 . 16587 1 449 . 1 1 94 94 VAL N N 15 128.61 0.2 . 1 . . . . 93 VAL N . 16587 1 450 . 1 1 95 95 LYS H H 1 8.79 0.02 . 1 . . . . 94 LYS HN . 16587 1 451 . 1 1 95 95 LYS N N 15 127.7 0.2 . 1 . . . . 94 LYS N . 16587 1 452 . 1 1 96 96 TRP H H 1 8.79 0.02 . 1 . . . . 95 TRP HN . 16587 1 453 . 1 1 96 96 TRP HB2 H 1 3.55 0.02 . 2 . . . . 95 TRP HB2 . 16587 1 454 . 1 1 96 96 TRP HD1 H 1 7.19 0.02 . 1 . . . . 95 TRP HD1 . 16587 1 455 . 1 1 96 96 TRP HE1 H 1 10.57 0.02 . 1 . . . . 95 TRP HE1 . 16587 1 456 . 1 1 96 96 TRP HZ3 H 1 7.55 0.02 . 1 . . . . 95 TRP HZ3 . 16587 1 457 . 1 1 96 96 TRP NE1 N 15 130.05 0.02 . 1 . . . . 95 TRP NE1 . 16587 1 458 . 1 1 97 97 ASP H H 1 8.56 0.02 . 1 . . . . 96 ASP HN . 16587 1 459 . 1 1 97 97 ASP HA H 1 4.55 0.02 . 1 . . . . 96 ASP HA . 16587 1 460 . 1 1 97 97 ASP HB2 H 1 2.78 0.02 . 2 . . . . 96 ASP HB2 . 16587 1 461 . 1 1 97 97 ASP HB3 H 1 2.53 0.02 . 2 . . . . 96 ASP HB3 . 16587 1 462 . 1 1 97 97 ASP N N 15 131.57 0.2 . 1 . . . . 96 ASP N . 16587 1 463 . 1 1 98 98 ARG H H 1 7.41 0.02 . 1 . . . . 97 ARG HN . 16587 1 stop_ save_